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ABSTRACT
Irogesteronei Inhibition of Female Rat Sexual Behavior
And Investigations of Its Mechanism of Action
(September 197?) -
Jeffrey D. Blaustein, B.S., University of Massachusetts
M.S., University of Massachusetts
Ph.D., University of Massachusetts
Directed by: Professor George N. Wade
Chronic injections of high doses of progesterone (5 mg) and
low doses of estradiol benzoate (EB; 2 ug) resulted in less sexual
behavior than low doses of progesterone (0.5 mg) and low doses of
EB. In a typical procedure for inducing sexual behavior, EB and.
progesterone were given sequentially, separated by ^2 hours. High
levels of progesterone (2.5 and 5 mg) administered, concurrently with
EB inhibited, the induction of sexual receptivity (concurrent inhi-
bition). Increasing the dose of EB from 2 ug to 6 ug otr 10 ug
offset this inhibition. High doses of progesterone (5 mg) admin-
istered, simultaneously, or 2 to 16 hours prior to EB, inhibited, the
induction of sexual behavior, but the inhibition was less if proges-
terone was administered. 48 hours prior to EB. A single injection of
progesterone (l mg) that does not inhibit the induction of sexual
behavior when administered concurrently with EB inhibited, lordosis
if distributed, into five injections (0.2 mg) every 4 hours.
When a large dose of progesterone was administered, to oveiri-
ectomized rats 2k hours after a 2 ;ug injection of estradiol
benzoate, sexual receptivity was inhibited. 30 hours later (sequential
inhibition). Larger doses of progesterone (l mg) were required to
Vinhibit the induction of sexual receptivity when tested ^ hours
after administration than were necessary to facilitate sexual
behavior 30 hours after EB. This inhibition was not due to copulatory
stimuli from the first test, because inhibition occurred, even if the
first test was omitted.. The degree of inhibition of sexual behavior
produced, by progesterone was dose dependent on estradiol; increasing
the EB priming dose offset the inhibition caused by 1 mg of progester-
one.
The results of two experiments in which progesterone did not
inhibit the uptake or retention of -^H-estradiol by brain cell nuclei
suggest that the antiestrogenic action of progesterone in the central
nervous system is not d.ue to interference with the binding of estra-
diol. The results of an experiment which dissociated behaviorally
the antiestrogenic action of progesterone from that of a synthetic
antiestrogen, CI-628, are consistent with the notion that progesterone
and synthetic estrogen antagonists inhibit the behavioral effects of
estradiol by separate mechanisms.
A synthetic progestin, 17<<, 21-dimethyl-19-nar-pregna-4,9-
diene-3,20-dione (R5020), was 5O-IOO times as effective as progester-
one in facilitating (5 >u€ vs. 250 ;ug), sequentially inhibiting (10 yUg
vs. 1,000 ;ug) and. concurrently inhibiting (50 v% vs. 2,500 jig)
female sexual behavior in ovariectomized rats. This progestin, which
binds to mammalian uterine progestin receptors with higher affinity
than progesterone, is bound, in vivo by cell nuclei from uterus,
pituitary, hypothalamus, preoptic area - septum and cortex of ovari-
ectomized-adrenalectomized. rats. Binding is dependent on estrogen
pretreatmenti it is saturable (suppressed more by pretreatment with
vi
R 5020 or prog.-sterone than by corticosterone or testostetrone)
.
The li.zk of binding after ^H-progesterone injection is attributed
to the more rapid dissociation of progesterone from its receptor.
These studies support the hypothesis that binding of progestins by
brain cell nuclei may be a prerequisite for at least some behavioral
responses to progestins.
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INIRODUCTION
Progestins antagonize and facilitate the effects of estradiol
on various behaviors. Progestins have no apparent behavioral
effects. that do not require an interaction with estrogens (Feder
& Marrone, 1977; Morin, 1977). The facilitatory effect of proges-
terone after estrogen priming on female sexual behavior has been
observed, in guinea pigs (Collins, Boling Dempsey & Young, I938),
rats (Beach, 19^2; Boling & Blandau, 1939) and hamsters (Carter &
Porges, 197^, Frank & Fraps, 19^5).
Although sexual behavior can be induced, in ovariectomized (OVX)
rodents by estrogens alone (guinea pigs: Boling, Young & Dempsey,
1938; Dempsey, Hertz & Young, I936, rats: Davidson, Smith, Rodgers
& Block, 1968; Edwards, Whalen & Nadler, I968; Green, Luttge &
Whalen, 1970; hamsters: Carter, Michael & Morris, 1973), progestins'
involvement in the induction of sexual behavior during the estrous
cycle is obligatory. By ovariectomizing at a time which prevents the
preovulatory progesterone surge (Croix & Pranchimont, 1975; Feder,
Resko & Goy, I968; Butcher, Collins & Fugo, 1974; Lukaszewska &
Greenwald., 1970), it has been demonstrated, that endogenous estrogen
is not sufficient to induce sexual receptivity in guinea pigs (Joslyn,
Fed.ea:, & Goy, 1971) » rats (Powers, 1970) or hamsters (Ciaccio &
Llsk, 1971). In estrous cycling rodents, the induction of sexual
behavior requires not only estrogen priming, but also a subsequent
surge of progesterone from either an exogenous or endogenous source.
The use of ovariectomized rodents with sexual behavior induced
by controlled, doses of hormone enables more complex interactions
2of estrogens and. progestins to be investigated and parcelled out.
For example, when progesterone is administered at various intervals
after a sufficient dose of an estrogen, heat occurs with shorter
latency with a more discrete duration and in a larger percentage of
guinea pigs than with estrogen-induced, heat (Collins et al., I938;
Young, 1969; Zucker & Goy, I967). The addition of progesterone
also results in a more consistent latency to heat and in an increase
in the duration that the lordosis posture is held (Zucker & Goy,
1967), Increasing doses of progesterone may increase the duration
of heat in guinea pigs (Joslyn et al., I97I; but cf. Dempsey et al.,
1936). Heat terminates despite high plasma levels of progesterone
(Morin & Fed.er, 1973). Thus, progesterone seems to increase heat
duration, but it also causes its termination.
In experiments with rats, measurements do not usually include
latency to onset of sexual receptivity or its duration, since sexual
receptivity changes £ls a result of repeated, testing (Hardy & DeBold,
1972). Nevertheless, the percentage of rats that become sexually
receptive when estrogen is followed, by progesterone is greater than
with estrogen alone (Beach, 19^2; Boling & Blandau, 1939).
The role of progesterone in the induction of sexual behavior
in the golden hamster appears to be no different than in guinea pigs
or rats. Whereas estradiol alone is followed, by estrous behavior
in only a few percent of ovariectomized hamsters, if sufficient
quantities of progesterone are administered. 24-48 hours after estra-
diol, all or nearly all of the females become sexually receptive
(Frank & Fraps, 1945). As with guinea pigs, a progesterone injection
increases lordosis duration and decreaLses the latent period in
3hamsters administered, daily injections of estradiol
. When a single
estrogen injection is followed by a single progesterone injection,
increasing doses of progesterone result in an increase in the per-
entage of hamsters in heat and in the lordosis duration during a test
(Caxter & Forges, 1974),
Besides facilitating the actions of estrogens in the induction
of sexual receptivity, progesterone is the most potent naturally-
occurring antiestrogen. In I936, Dempsey, Hertz & Young first sug-
gested, "the presence of a functional corpus luteum.
.
.might counteract
the effect of (estradiol)" on the induction of sexual behavior in
female guinea pigs. When sufficient levels of progesterone are
present during the time of estrogen conditioning''", the induction of
sexual behavior is inhibited, ( concurrent inhibition
.
Powers &
Moreines, 1976). Concurrent inhibition has been distinguished, from sequen-
tial inhibition which occurs subsequent to the completion of estrogen
conditioning of sexual receptivity.
The role of progesterone in the inhibition of sexual behavior
has been well-documented, for guinea pigs (Goy & Phoenix, 1965;
Wallen, Goy & Phoenix, 1975; Zucker, I966; Zucker & Goy, I967).
In intact guinea pigs, a substance of ovarian origin, presumably
progesterone, has a transient concurrent inhibitiory influence on the
induction of sexual receptivity. Goy et al.
,
(I966) have shown that
estradiol benzoate progesterone induction of sexual receptivity
1
Estrogen "conditioning" is shorthand and. refers to the changing state
of the central nervous system substrate. It is considered to be
complete when a progesterone injection will induce sexual behavior.
is Inhibited during the luteal phase of the guinea pig estrous
cycle. If they attempted, to induce heat during most stages of
pregnancy, no lordosis was ohserved (Goy et al., I966). When guinea
pigs were administered EB + progesterone beginning on Bay 9 of the
estrous cycle, generally none or few of the animals became sexually
receptive (Goy et al., I966; Zucker, I968). If, however, the animals
were ovariectomized. at either the time of, 12 hours, or 18 hours after
the EB injection, neaxly all of the animals became receptive. When
ovariectomy was performed Zk or 36 hours after EB, sexual receptivity
was inhibited (Zucker, I968).
When ovariectomized, guinea pigs received an injection of proges-
terone two hours prior to 6 ;ug of estradiol benzoate, the percentage
of animals becoming sexually receptive following a second injection
of progesterone 36 hours later was inversely related, to the dose of
the first (inhibitory) injection; 0.5 mg was adequate to inhibit
sexual receptivity in all animals (Goy & Phoenix, I965; Wallen et al.
,
1975). One mg of progesterone administered either six hours after
estradiol benzoate or up to 2^ hours prior to the estradiol benzoate,
inhibited the induction of sexual behavior when tested after an
additional progesterone injection 36 hours later (Wallen et al.
,
Zucker, I966). The progesterone injection decreased, the percentage
of guinea pigs becaning sexually receptive, slightly increased the
latency to lordosis and also decreased, the duration of heat when
compared, with animals that either received, no concurrent proges-
terone or received, it 48 or 72 hours prior to estradiol.
The results of Wallen et al., (1975) clearly demonstrate that
the interval, between progesterone and estradiol is critical in
5inhibiting sexual behavior. If the progesterone injection precedes
the estradiol injection by too long a duration, inhibition is not
observed. In fact, using supporting radioimmunoassay data of blood
progesterone levels following subcutaneous progesterone injections,
they suggest that the inhibition is directly related to blood
plasma progesterone concentrations. A similar temporal dependence
of inhibition on progesterone has also been demonstrated in intact
guinea pigs by Zucker (I966).
Relatively little is known of progesterone 's inhibitory effects
on sexual behavior in rats. In retrospect, the originally reported
failure to inhibit sexual behavior in ovariectomized rats with
injections of either 0,l6 mg or 1 mg of progesterone given simul-
taneously with, or twelve hours subsequent to injections of 6 Mg of
estradiol benzoate is not surprising (Zucker, 1967a). Edwards,
Whalen & Nadler (I968) found that 5 ug EB + O.5 mg progesterone
daily for ten days induced high levels of receptivity as measured on
the tenth day of treatment. On the contrary, 5 wg EB + 5 mg of
progesterone induced levels approximately 50?^ that of the group
that received low levels (0.5 mg) of progesterone. Thus, inhibition
in rats seems to depend on high doses of progesterone.
When Powers and Zucker (1969) attempted to induce sexual be-
havior during pregnancy and pseud©pregnancy with estradiol benzoate,
they obtained indirect evidence that suggested that high levels of
progesterone may be required to concurrently inhibit sexual behavior.
During pregnancy, EB was injected and followed 24 or 48 hours later
by testing for sexual behavior (Powers & Zucker, I969). Two wg of
EB induced sexual behavior if administered on Day 0, but not if
injected on Days 3-15 of pregnancy. On the .ther hand. 6 of EB
induced low levels if administered on Day 5, moderately high levels
if administered on Day 10 but did not induce heat if administered
on Day I5. Since it is known that plasma progesterone levels first
exceed estrous-cycle levels on Days 2-5 of pregnancy and peak at
around Day I5 (Fajer & Barraclough, 196?; Hashimoto. Henricks.
Anderson & Melampy. I968). this suggested that progesterone may be
causing inhibition of sexual behavior induced by EB. Even more
striking, however, is the demonstration that 6 ug of EB can induce
sexual behavior at times at which 2 of EB cannot, demonstrating
a dose dependency on estradiol as well as the indirect suggestion of
dose dependency on progesterone. This latter dependency is, of
00UIS8, purely correlational and is simply based on the fact that
inhibition correlates with progesterone levels. The same relation-
ships were obtained, on the corresponding days of pseud opregnancy.
Thus, assuming that progesterone is responsible for the inhibition
during pregnancy, relatively low levels of progesterone can inhibit
the induction of heat with low doses of EB, but higher doses of EB
can offset this inhibition; high levels of progesterone can inhibit
even higher doses of EB, at least up to the 6 Mg of EB used in this
experiment. These studies therefore, raise the possibility that in-
hibition of sexual receptivity in rats by progesterone may be
critically dependent on the relative doses of progesterone and estra-
diol benzoate administered.
Following the period of sexual receptivity, a refractory period
ensues in guinea pigs during which a subsequent injection of proges-
terone does not facilitate another episode of sexual behavior
(Bollng, Young i Dempsey, I938). This period, which is of variable
duration, can be influenced by the progesterone dose (Wallen, Goy
tc Phoenix, 1975; Zucker, I966; Zucker & Goy, I967), additional
estradiol administered (Zucker, I966) and the interval between the
first and second progesterone injection (Zucker, I966). This type
of inhibition has been referred to as sequential inhibition
. Boling
et al. (1938) first demonstrated that following the induction of
heat by estradiol benzoate + progesterone, a second injection of
progesterone does not reinduce sexual receptivity, although sexual
receptivity can be induced if the first progesterone injection
is omitted (Collins, Boling, Dempsey & Young, I938). Following
termination of estrogen-induced heat, however, progesterone did
induct a second period of sexual receptivity, thus demonstrating
that it is not sexual receptivity 2^ se, hut progesterone that
inhibits reinduction of sexual behavior.
In subsequent work with ovariectomized guinea pigs (Zucker,
1966) sexual receptivity was first induced by estrogen + progesterone.
At various time intervals after this progesterone injection, a
second progesterone injection was administered. As the latency to
the second progesterone injection increased from 12 to 171 hours,
there was a tendency for more frequent recurrence of heat, but even
at 171 hours, only one-third of the guinea pigs became receptive.
It has recently been demonstrated that inhibition of sexual
behavior can occur without prior facilitation. When guinea pigs
were primed with 3»3 of estradiol benzoate and tested for sexual
receptivity with only 15 Ug of progesterone at 36 hours, the lordosis
of 65?^ of the guinea pigs was inhibitied when tested with 0.6 mg of
progesterone at 60 hours (Morin & Feder, 1974a). In a further
analysis it was shown that of the animals that were not receptive
in the first test, only 20fo of them responded on the second; of
the animals which were receptive on the first test, 50?S responded
on the second test. This is accepted as evidence that a lower dose
of progesterone is required for inhibition than facilitation with
this procedure. It is obvious that this particular set of results
is probably critically dependent on the interval between progesterone
injections (cf. Zucker, I966). Presumably, if Morin and Feder (1974)
had waited longer than 60 hours for the second progesterone injection
and test, a greater quantity of progesterone would have been re-
quired for inhibition.
Boling et al. (1938) had initially demonstrated that following
EB + progesterone induction of heat, guinea pigs can readily be
induced, to exhibit a second episode of receptivity if EB is ad-
ministered prior to the second progesterone injection. Actually
most of their guinea pigs could be brought into four or five separate
episodes in fifteen days if the sexual behavior was induced by EB +
progesterone. Using different doses of hormones than in previous
work, Zucker (1966; 6 jjg EB + 0.4 mg progesterone) was capable of
reinducing sexuaJ. receptivity if the latency from the first proges-
terone injection to the second estradiol injection was of long
enough duration. As the latency increased from 6 hours to I5 hours
to 58 hours, increasing numbers of the guinea pigs became sexually
receptive, and maocimum lordosis duration increased.
The refractory period depends on adequate dose of progesterone
for the first progestin injection. As the dose of the first
8progesterone injection increases, fewer anim-.ls become receptive
following a second progesterone injection (Zucker & Goy, I968; Goy
& Phoenix, I965; Wallen^al., 1975).
The results of Boling et al. (1938) that had shown that guinea
pigs could be repeatedly brought into heat by EB + progesterone are
consistent with those of Zucker (I966) and Zucker & Goy (196?)
that had shown that under some circumstances, guinea pigs could be
successively brought into heat and under some circumstances they
could not. Taking into consideration the dose dependency of the
inhibition on progesterone (Goy & Phoenix, 1965; Wallen et al., 1975;
Zucker & Goy, I967) and the temporal dependence of the progesterone
and estradiol injections (Zucker, 1966), it becomes obvious that if
a wide range of hormone dosages are not tried, contradictory results
can readily be obtained. This fact may well account for the early
conflicting findings in rats.
As was the case with concurrent inhibition, first attempts to
obtain sequential inhibition in ovariectoraized rats were unsuccessful
(Zucker, 1967a). Ovariectomized rats were injected with 6 pg EB
followed at 36 hours with 0.^ mg of progesterone. Most of the rats
were sexually receptive when they were tested k2\ hours after EB.
Sixty hours after the initial EB injection progesterone was again
administered.. This resulted in lordosis qubtients which were not
significantly lower thain those obtained on the first test. The
results were different from those obtained in guinea pigs and were
unexpected in light of the fact that exogenously administered pro-
gesterone inhibits sexual receptivity during the estrous cycle
in
rats (Zucker, 1967b). Progesterone administered on any of the
first
10
three days of -^he four-day estrous cycle delayed, the occurrence of
sexual behavior (Zucker, 1967b),
In Zucker 's attempt to obtain progesterone-induced sequential
inhibition in ovariectomized. rats, doses of estradiol and proges-
terone were chosen which were known to be effective in guinea pigs
(Zucker, 1967a). However, rats suid guinea pigs differ in their
responsiveness to progesterone (WsuJe et al., 1973). Specifically,
rats are less sensitive to progesterone than guinea pigs in the
facilitation of sexual behavior (Powers & Valenstein, 1972; Wade
& Feder, 1972), and perhaps more sensitive to estradiol than
guinea pigs (Boling & Blandau, 1939; Dempsey et al.
,
I936). Nadler
(1970) attempted to induce a refractory period in ovariectomized rats
using smaller quantities of estradiol benzoate than had. been previ-
ously used. One microgram of estradiol benzoate was injected at
both 0 and. 2k hours. At 48 hours, oil or 0.5 mg of progesterone was
administered, and. rats tested, for receptivity. A day later (72 hours)
0.5 rog of progesterone was administered and. rats were tested again
for receptivity. In this situation, the second progesterone injection
was ineffective in reinducing sexual receptivity in rats that had
received, progesterone at 48 hours. Thus, with these particular
dosages of hormones, a progesterone-induced refractory period was
observed in rats. That this refractory period, was due to proges-
terone and not to copulatory stimuli (Hardy & Debold, 1970) was
demonstrated by omitting testing in one group after the first
progesterone injection. The next day's progesterone injection then
failed to facilitate sexual behavior. If EB injection was added at
the time of the first progesterone injection, no refractory period
11
was evident. This suggests that progesterone may induce a refractory
period under appropriate circumstances and that this inhibition i^;
in part dependent on low levels of estrogen; increasing titres of
estrogen apparently overcome this inhibition
.
Lisk (1969a, 1969b) used another approach to obtain a proges-
terone-induced refractory period. Cannulae filled with estradiol
were implanted into the anterior-hypothalamus-preoptic area of
ovariect oral zed female rats. After 72 hours, progesterone was im-
planted subcutaneously and rats tested frequently over a period of
72 hours for receptivity. Progesterone first facilitated sexual
behavior, but by 72 hours the facilitation was absent. If the sub-
cutaneous progesterone implant was then removed but reimplanted four
days later, the progesterone once again facilitated the induction
of sexual behavior. This experiment, however, was confounded by the
fact that the same animals were tested several times over the testing
period. Lisk, unfortunately, did not take into account the possi-
bility that prior copulatory stimuli may have contributed to his
results (Hardy & Debold, 1972).
In an investigation of the refractory period as it relates to
the estrous cycle. Powers (1970) attempted to determine if progest-
srone acts to inhibit receptivity during the estrous cycle. When
rats were ovariectomized either before or during the progesterone
surge, a progesterone injection 12 to 18 hours after an initial
testing for receptivity on the night of proestrus was ineffective
in Inducing a second episode of receptivity. Since one pg of EB
injected at the time of or prior to ovciriectomy overcame this in-
hibition, the data suggest that during the estrous cycle the
12
refractoriness may be due to the lack of estr-dlol rather than to
the presence of progesterone. It should, however, be emphasized
that there is no time during the estrous cycle when ovariectomy can
be performed so that the progesterone surge is blocked (to demonstrate
that progesterone is necessary for the refractoriness), yet estradiol
secretion remains normal (to demonstrate that diminished estradiol
levels are not responsible for the refractoriness). In fact,
Powers' (1970) early ovariectomies occurred during the estradiol
surge (Butcher, Collins & Fugo, 197^) so that both estradiol and.
progesterone levels may have been diminished.
Barfield and Lisk (197^) combined timed ovariectomies with
exogenous hormones. The results of their work suggest that the
endogenous progesterone surge induces a refractory period to in-
duction of receptivity by estradiol + progesterone. This, of course,
contradicts Powers' (1970) interpretation in that a prior proges-
terone surge inhibited the induction of receptivity in rats when
estradiol levels were othervrise high enough to induce heat.
Using a similar procedure. Powers and Moreines (1976) found
however, the presence or absence of a sustained elevation in
progesterone levels was without effect on estradiol + progesterone
induction of sexual behavior during the estrous cycle. As the authors
point out, the procedure was one of concurrent inhibition, not
sequential inhibition. During the naturally occurring estrous cycle
inhibition should, be of the sequential type, simply because the peak
in plasma progesterone concentration occurs after the peak in
estradiol concentration. In addition, it should not be surprising
if the endogenous progesterone surge does not inhibit the induction
13
of sexual behavior by the dose of estradiol that they used (26.? ^/
kg body weight).
Using a sequential Inhibition procedure rather than a concurrent
inhibition procedure, Powers and Morelnes (1976) obtained what appears
to be a progesterone-induced refractory period to subsequent stimu-
lation by progesterone. With this procedure in which the rats'
endogenous estradiol was used to condition sexual behavior, its
own progesterone used for inhibition and an exogenous progesterone
injection used for subsequent facilitation, Powers and Moreines
(1976) report some Inhibition by the endogenous progesterone.
In order to predict how progesterone might act on the brain
to exert its effects on behavior that have been outlined, a prior
understanding of progesterone 's mechanism of action in more
thoroughly-studied tissues is helpful. The model of the Initial
interaction of a steroid hormone with reproductive tissues has been
described, and recently reviewed by several authors (G orski & Cannon,
1976; Jensen & DeSombre, 1973; O'Malley & Means, 197^^ Yamamoto &
Alberts, 1976). Basically, this model postulates that a steroid
hormone enters a cell, binds to a cytoplasmic receptor permitting
translocation of the steroid-receptor complex to the cell nucleus
where It initiates an alteration In gene expression. Although
initially proposed, for estrogen's Interaction with uterine cells (G orski,
Toft, Shyamala, Smith & Notides, I968; Jensen, Suzuki, Kawashima,
Stumpf, Jungblut & DeSombre, I968), the "two-step" model has
2
Although admittedly an oversirapliflcation, for convenience this
model will be referred to as the "two-step" model (Jensen et al.
,
1968) to emphasize its dependence on cytoplasmic and nucleaar binding.
since been extended, in entirety or in part to the interaction of all
steroid hormones with their respective target tissues (Gorski &
Gannon, I976'; Jensen & DeSombre, 1973; O'Malley & Means. 197k)
including the central nervous system (McEwen & Pfaff
,
I973. McEwen,
Denef, Gerlach & Plapinger, 197^? McEwen, 1975; McBwen, I976).
The utility of such a model for progesterone 's mechanism of action
is indisputable. It has led to tremendous advances in delineating
progesterone 's mechanism of action in the chick oviduct, and recently
to advances in owe understanding of its action in the mammalian
uterus
.
The model target tissue for progesterone' s mechanism of action
in modulating gene expression is the chick oviduct because of its
well-documented response of synthesis of the egg-white proteins,
avidin and ovalbumin under discrete hormonal conditions (Schimke,
McKnight, Shapiro, Sullivan & Palacios, 1975; O'Malley, McGuire,
Kohler & Korenmeum, I969). Progesterone in either estrogen-
stimulated, or estrogen-withdrawn chicks induces the synthesis of
avidin (O'Malley et al.
,
I969; Korenmann & O'Malley, I968; Means &
O'Malley, 1971); ovalbumin synthesis is induced by either estrogens
or estrogens and progesterone (O'Malley et al., I969; Palmiter,
1972). The intermediary mechanism of progesterone 's action on
avidin synthesis is believed to be as follows. High affinity
progestin-specific binding proteins are present in the cytoplasm of
oviduct cells (Sherman, Corvol & O'Malley, 1970; O'Malley, Sherman
& Toft, 1970). Administration of progesterone results in binding
to these cytoplasmic receptors (O'Malley, Toft & Sherman, 1971)
and subsequent trsuislocation to the nuclear compartment (O'Malley
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et al.. 1971) where the hormone-receptor complex binds to chromatin
acceptor sites (Spelsberg. Steggles & O'Malley. I971). One subun.t
of the hormone-receptor protein is believed to bind with high affinit
to a limited number of sites on DNA (O'Malley & Schrader, I972). and
one subunlt to nonhistone proteins (Spelsberg. Steggles. ChytlA
O'Malley, 1972; Schrader, Toft & O'Malley, 1972). At this site it
may increase the number of RNA chain initiation sites available to
RNA polymerase (Schwartz, Kuhn, Buller. Schrader & O'Malley, I976).
thus stimulating synthesis of specific species of mRNA (O'Malley &
HcGuire, I969). The transcriptional products are transported to the
cytoplasm where the endpoint of translation into avidin may take
place (O'Malley & Means, 1974). In the estrogen-stimulated chick
oviduct, this specific response may occur despite the fact that
progesterone may also cause a transient decrease in total protein
synthesis (Means & O'Malley, 1971 ).
In mammals, the model system for progesterone 's mechanism of
action is of course, that organ in which progesterone exerts some of
its most obvious morphological effects, the uterus. In the rodent
uterus, progesterone both synerglzes with and. antagonizes estrogens'
stimulation of various biochemical and physiological events. Pro-
gesterone administered by itself has little (Bronson & Hamilton,
1972? Harris, Lerner & Hilf, I968) or no (Harris et al., I968 ; Wade
& Feder, 1974) effect on most uterine responses, althugh the fact
that it can, by itself, induce deciduoma formation (Madjerek, 1972;
Madjerek & Smit-vis, 1974; O'Malley & Strott, 1973) and corrugation
of the luminal epithelium (Martin, Finn & Carter, 1970) cannot be
overlooked. Progesterone facilitates estrogens' effects on responses
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such as increases in uterine weight (Bronson i Hamilton, I972), RNA
Synthesis (Bronson 4 Hamilton, 1972, Miller, 1975). protein synthesis
(Bronson & Hamilton, 1972; Wade & Feder, 197^), RNAiDNA ratios (Bron-
son & Hamilton, 1972), stromal mitosis (Clark, I97I; Clark, 1974)
and endometrial proliferation (Zarrow, Yochim & McCarthy, 1964).
Progesterone can induce decidualization (Yochim & DeFeo, I962) and
stimulate the change of the endometrium from a proliferative phase
to a secretory one (Finn & Porter, 1975; McPhail, 1934).
Within prescribed dosage and temporal parameters, progesterone
also antagonizes most of estrogens' effects including many of the
same responses which it facilitates. Progesterone inhibits
estrogen-induced increases in uterine wet weight (Harris et al., I968;
Hsueh, Peck & Clark
, 1975; Bo, Poteat, Krueger & McAlister, I97I;
Martin & Finn, 1970 ), RNA synthesis (Bronson & Hamilton, 1972),
protein synthesis (Bronson & Hamilton, 1972), DNA synthesis (Bronson
& Hamilton, 1972; Krueger, Bo & Garrison, 1974), RNAtDNA ratios
(Harris et al., I968), luminal and glandular epithelium mitosis
(Clark, 1971» 197^; Martin & Finn, 1970), cAMP levels (Rinard &
Chew, 1975) » phosphorylase a levels (Rinard & Chew, 1975) » glucose-
6-phosphate dehydrogenase activity (Harris et al., I968), lipid
content (Harris et al., I968), retention of luminal fluid (Bo et al.
,
1971 t Kennedy & Armstrong, 1975; Cleraetson Verraa & DeCarlo, 1977;
Armstrong, I968), glycogen concentrations (Zarrow et al.
,
1964; Bo
et al., 1971) » and of course myoraetrial contractions (progesterone
block! O'Malley & Strott, 1973; Davies & Ryan, 1972; but possibly
not in the guinea pig. Porter, 1970).
Whether progesterone facilitates or antagonizes estrogens'
on
action on a par.ticular response seems to be critically dependent
both tne injection regimen and dosage parameters for both hormones.
In rats and mice, combined treatment with estrogen + progesterone
far one (Bo et al., 1971), three (Hsueh et al., 1975), four (harris
et al, 1968) or seven (Muggins & Jensen, 1955) days antagonizes
uterine growth. Conversely, Bronson & Hamilton (1972) demonstrated
the progesterone synergizes with estradiol to increase uterine wet
weight in some ciroumstajices. When estradiol was administered on
Days 1-3 and 7, the addition of progesterone on Days 4-7 resulted
in more growth than when progesterone was omitted.
Early attempts to demonstrate specific progestin binding in
the rodent uterus failed. With autoradiographic techniques,
progesterone was not found to concentrate in any subcellular fraction
(Rogers, Thomas & Yates, I966; Taylor & Wright, 1971). Likewise,
other early attempts to measure in vivo uptake of radioactively
labeled progesterone into uterine tissue revealed little or no
concentration relative to nontcirget tissues (Riegel, Hartop &
Kittinger, 1950; Berliner & Wiest, I956; Wiest, I963; Lawson &
Pearlman, 1964; Laumas & Farooq, I966) . In 1970, Falk and. Bardin
(1970) reported ^ vivo uptake of -^H-progesterone in the guinea pig
uterus, and. in that year Milgrom and Baulieu (1970) reported proges-
terone binding by the cytosol of rats* uterus.
The major obstacle to characterizing progesterone binding has
been the rapid dissociation of progesterone from its cytoplasmic
binder (Feil, Glasser, Toft & O'Malley, 1972). Several procedural
adaptations have been used recently which circumvent this inherent
technical problem by decreasing the rate of dissociation. Thio-
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glycerol is of en used in buffers because it stabilizes some forms
of the chick oviduct progesteone receptor (Schrader, 1975; Schrader,
Smith k Coty, 1976). Addition of glycerol to buffers markedly
slows dovm the dissociation rate of progesterone from its mammalian
uterine receptor (Fell et al., 1972). With a charcoal adsorption as-
say, Fell, Glasser, Toft & O'Malley (1972) have shown that glycerol
may actually increase the half-life of the hormone-receptor complex
by as much as 10-15 times. Lastly, a highly potent synthetic pro-
gestin, 17*<, 21-dimethyl-19-nor pregna-4,9-diene-3,20-dione, has
been used to dissociate progestin-specific binding from less-
specific binding (Philibert & Raynaud, 1973; Philibert & Raynaud, 1974).
Part of the early ambiguity in the understanding of progesterone
binding in mammalian uterus may have been due to the fact that the
high affinity binding component is dependent on estrogen priming
(Chen & Leavitt, 1975). Estrogen pretreatment seems to be a pre-
requisite for high levels of progesterone binding, a fact consistent
with progesterone 's dependence on estrogen priming for most physiolog-
ical responses. Estrogen injections dramatically increase the
amount of in vivo binding in the uterus but not nontarget tissues
of rodents (Corvol, Falk, Freifeld & Bardin, 1972; Falk & Bardin,
1970; Leavitt & Blaha, 1972). This increase is also seen with in
vitro assay of progesterone binding (Chen & Leavitt, 1975; Leavitt
et al,,1974; Milgrom, Atger & Baulieu, 1970; Freifeld, Feil & Bardin,
1974; Luu Thi, Baulieu & Milgrom, 1975; Faber, Sandraann & Stavely,
1972a, b). In an iji vitro assay using hamster uterine strips incu-
bated, with estradiol, the increatse in progesterone binding was
found to be protein-synthesis-dependent since it is inhibited by
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cyclohexlmidfi ^Faber, Saffran, Chen & Leavitt, I976), and RNA-
synthesis-dependent since it is inbhibited when actinomycin-D is
present prior to, but not after, the sixth hour of a 12 hour incu-
bation (Faber et al., I976.
A central requirement of the two-step model for progesterone'
s
action is that the hormone bound to its receptor is translocated to
the cell nucleus. Using autoradiography, concentration of radio-
activity has recently been found over cell nuclei of the uterus
after injection of ^H-progesterone (Warmebourg, 1974; Stumpf & Sar,
1973). With liquid scintillation techniques tritium has been re-
covered, from cell nuclei of the uterus after
-^H-progesterone injection
(Atger, Baulieu & Milgrom, 197^; Fell, Miljkovic & Bardin, 1976).
A progestin-specific receptor has been reported in the nuclei of
*at uterine tissue by an exchange assay (Walters & Clark, I976;
Hsueh, Peck & Clark, 197^). Following a progesterone injection, cyt-
oplasmic progesterone receptors are depleted and. progesterone recep-
tors accumulate in the nuclear fraction. This presumably represents
translocation of the receptor from the cytoplasm to the nucleus (Saffrsin,
Loeser, Bohnett & Faber, I976 ; Walters & Clark, 1975; Hseuh et al.,
197^) • These reports .are consistent with the notion that binding
which appeairs in the nucleus is actually due to transformed and.
translocated, cytoplasmic receptors (Fell Sc Bardin, 1975). In
3
experiments of in vivo binding of H-progesterone, however, only slightly
more radioactivity accumulates in the nuclear fraction than in the
cytosol (Atger et aO... 197^1 Fell et aJ., 1976). Although this is not
strong evidence for a nuclear site of action far progesterone, the
date are _not inconsistent with the "two-step" model of steroid action
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(Gorski & Gannon, I976; Jensen & DeSombre, I973; O'Malley & Means,
1974).
There have been numerous reports of failure to extend the "two-
step" model of progesterone action to the pituitary gland and. the
central nervous system. Many reports have demonstrated that in vivo
uptake into whole homogenates of these tissues is nonsaturable
(Wade & Feder, 1972a; Luttge, Wallis & Hall, I97/+; Iramain & Strott,
1973; Whalen & Gorzalka, 197^) and. seems to be nonspecific. Its
only selectivity seems to obey a rule similar to the "polarity rule"
by which steroids bind to plasma proteins (Westphal, 1973). Less
polar steroids are taken up in greater concentrations and. retained
more than steroids with greater polarity (Wade & Feder, 1972b).
In this nonsaturable system, uptake in midbrain is greater than
in hypothalamus which is greater than cortex (Wade & Feder 1972a;
Luttge et al., 197^; Wade & Feder, 1972b; Seiki, Miyamato, Yameshita
& Kitani, I969; Luttge, Chronister, & Hall, 1973; Wade, Harding & Feder,
1973; Whalen & Luttge, 1971a, b). Highest uptake is sometimes observed
in the pituitary gland. (Whalen & Gorzalka, 197^; Luttge et al., 1973;
Whalen & Luttge, 1971; Presl, Figarova, Herzmann & Rohling, 1975).
There are minor differences between experimenters in the ordering of
other tissues, most of which may reflect variations in dissection
procedures
,
Reports of indirect evidence for satmrability of this whole
homogenate uptake system exist. Whalen' s group (Whalen & Gorzalka,
1974; Whalen & Luttge, 1971a, b) reports that adrenalectomy increases
the absolute concentration of radioactivity in most regions. How-
ever, others have pointed out that when tissue/plasma ratios are
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computed, which taJce into account the higher levels of radioactivity
in the blood, plasma of adrenalectomi.-sed. animals, this difference is
eliminated(Wade & Feder, 1972a, Zigmond, 1975). Subsequent experi-
ments in mice have failed to replicate the initial effects of
adrenalectomy (Luttge et al.
,
I973).
In vitro cytoplasmic receptor assays have had mixed results.
Sucrose density gradient centrifugation experiments have failed to
detect progestin binding in the hypothalamus or pituitary of rats
(Davies, Naftolin & Ryan, 197^; Davies, Siu, Naftolin & Ryan, 1975;
Kato, 1975), guinea pigs (Atger et^., 1974; Iramain, Danzo, Strott
& Toft, 1973) and hamsters (Reel & Shih, I975). Using gel filtration
both Seiki and Hattori (1973) in rats, and Iramain, Danzo, Strott and
Toft (1973) in guinea pigs have observed binders for progesterone in
the hypothalamic area and. pituitary; other experLmenters have failed
to confirm these findings (Atger et al., 197^). Luttge and Wallis
(1973) demonstrated, saturable binding in whole tissue of the inter-
peduncular region and pituitary, but no attempt was made to demon-
strate steroid, specificity.
With the exception of one series of experiments, attempts to
observe cell nuclear localization of radioactively labelled proges-
terone after in vivo injection have all failed (Atger ^ al., 1974;
Msirrone & Feder, 1977; McEwen, deKloet & Wallach, 1976). Although
3Karavolas reported concentration of H-progestins in crude hypothalamic
and. pituitary cell nuclei (Karavolas & Herf, 1971; Cheng & Karavolas,
1973; Robinson & Karavolas, 1973) 1 this binding: l) is not diminished
by boiling, which indicates that it is not protein-bound , and 2) is
not found, in purified, nuclei (Cheng & Karavolas, 1975a, b).
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In the on-j study which isolated cytosol after in vivo injection
of H-progesterone, high initial concentration and retention were
found in the median eminence and pituitary which is difficult to
reconcile with the hypothesized, nuclear site of action. They used a
very crude cytosol fraction (800 x £ for 10 minutes), so their
results may be attributable to contamination (Seiki & Hattori, I973).
With autoradiography, Sar & Stumpf (1973) found, nuclear con-
centration of tritium after an injection of "^H-progesterone in a
circumscribed, area which included, the arcuate nucleus, preoptic
periventricular nucleus and. preoptic suprachiasmatic nucleus after
an injection of H-progesterone. They also observed enhancement of
accumulation by estradiol priming and competition by unlabeled,
progesterone. Warembourg, however, failed, to replicate these findings.
The latter steps in progesterone 's central mechanism have been
studied, less extensively and. lend support to an action on protein
synthesis and. perhaps on transcription. Protein synthesis in rats'
neural tissues varies cyclically over the estrous cycle (Litteria,
1973; Moguilevsky, Sacchi, Christot, 1971). This effect is likely due
in part to estradiol's effects on translation (Wade & Feder, 1974).
Progesterone injection increases overall protein synthesis in all
areas of the brain that have been studied as well as in the uterus;
it has no effect in non-target tissues such as the diaphrcigm (Wade
& Feder, 1974). In addition, hypothalamic implants of the protein
synthesis inhibitor
,
cycloheximide have been shown to prevent
progesterone 's inhibition of sexual behavior in guinea pigs (Wallen,
Goldfoot, Joslyn & Paris, 1972). Progesterone 's positive feedback
on LH release is inhibited by systemic injections (Jackson, 1972) or
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hypothalamic Implants (Jackson. 1975) of the RNA synthesis Inhibitor,
actinomycin-D.
The purposes of this dissertation are three-fold. In Section
I, progesterone 's inhibitory effect on female sexual behavior in
rats Is partially characterized.. Section II tests the hypothesis
that progesterone' s antiestrogenic effects are mediated by a mechanism
such as that proposed, for the synthetic estrogen antagonists. In
Section III, the synthetic progestin. R 502O is used to investigate
the possibility that progesterone 's effects on sexual behavior are
mediated, by a "two-step" mechanism in the brain.
GENERAL PROCEDURE
Behavioral testing
.
Female Sprague-Dawley rats were purchased
from a commercial supplier (Charles River Breeding Laboratories. Wil
mington, Massachusetts). They arrived in the laboratory weighing
125-150 g and weighed 250-350 g at the time of testing. All animals
were housed in group cages with pine wood shavings as bedding.
Environmental illumination was provided from 2^00-1200 hours daily
and room temperature was maintained at 21-23°C. Purina Laboratory
Chow and tap water were available ad lib.
All animals were ovariectomized under methoxyflurane (Metofane)
anesthesia through a single midventral incision. After ovariectomy
rats were housed singly in Wahmann LG-75SA wire-mesh cages. Two
weeks later, rats were given 2 yg of EB followed 42 hours later by
0.5 fig of progesterone and were screened for the presence of lor-
dosis either by response to mounts by a male or by a manual stimu-
lation technique (Zucker, 1967b). Only females that showed lordosis
responses under these conditions were included in the experiments.
When an animal was used in two studies, approximately 2 weeks were
allowed to elapse between tests and subsequent injections. All
steroids were injected in 0.1 ml of sesame oil except where other-
wise noted.
All tests for lordosis took place in a 76-cm (diameter) round
testing arena with walls that were 15 cm high. Three sexually
experienced Sprague-Dawley male rats were adapted to the arena for
30 minutes prior to the introduction of the first female on a
given day. All tests occurred 1 to 3 hours alteac the onset of the
dark period under dim red illumination. Testing was done with the
experimenter blind to treatment groups. Tests consisted of ten
vigorous mounts with thrusting by the males. Quality of each
lordosis was rated as 0, 1. 2 or 3 (no, slight, moderate and full
dorsiflexion, respectively) after Powers and Valenstein (1972).
If an ejaculation occurred during a test, the female was removed
from the arena for 10 minutes.
In vivo- H-estradiol uptake
. Rats received injections of
2, 4, 6, 7- ^H-estradiol-17p (Specific Activity =91.3
Ci/mmole, New England Nuclear) dissolved in either oil or ethanol-
water {ZQP^)
,
administered through various routes, to be described
in each experiment. At a particular time after injection, rats
were anesthetized with sodium pentobarbital (Nembutal), a blood
sample taken in a heparinized syringe via cardiac puncture, and the
rats were perfused with 0.15 M cold saline. The brains were dis-
sected as described in each experiment and the entire pituitary
gland, removed. All steps were performed, at 4°C. Tissues were
weighed, to the nearest 0.1 mg and homogenized in Teflon-glass co-
axial homogenizers. An aliquot of the whole homogenate was taken
and. a purified, nuclear pellet isolated by the method of Zigmond and
McEwen (1970) using the following solutions: l) Nuclear Isolation I
(N I) — 0.32 M sucrose, 1 mM potassium phosphate, 3 ^ magnesium
chloride, 0.25% Triton X-100 (v/v), pH 6.5; 2) Nuclear Isolation II
(N 11) — .32 M sucrose, 1 mM potassium phosphate, 3 ^ magnesium
chloride, pH 6.5; 3) Nuclear Isolation III (N III) — 2.39 M
sucrose I 1 mM potassium phosphate, 3 ^ magnesium chloride, pH 6.5.
Tissues were homogenized with 20 slow up-aind-down strokes in 2 ml N I,
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Two hundred ul of whole horaogenate was taken and, the remainder centri-
fuged at 800 x g for 10 minutes. The supernatant was discarded,
the pellet resuspended in 2 ml N II; and. the mixture centrifuged at
800 X g for 10 minutes. The supernatant was discarded, the pellet
resuspended. in OA ml N II, and. 2.1 ml N III added and mixed
thoroughly. The mixture was centrifuged for 90 minutes at 20,000 x
g to obtain a nuclear pellet. The supernatant was discarded, and the
purified nuclear pellet removed from the centrifuge tubes with 3 x 500
ul 0.01 M citric acid.
Radioactivity was extracted from the whole homogenate and.
nuclear pellet fraction with 3 x 4 ml of toluene scintillation cock-
tail (5.0 g 2,5-diphenyloxazole and 0.05 g l»^bis-2(5-phenyloxazolyl)).
benzene/liter scintillation-grade toluene). After extraction of
radioactivity the whole homogenate and nuclear pellet fractions
were washed, with 5 rol of ethanol, and protein content was analyzed
by the method, of Lowry, Rosenbrough, Farr and Randall (I951).
Blood samples were centrifuged. and. 100 jul aliquots of plasma
pipetted into scintillation vials. Twelve ml of scintillation cock-
tail were added and the mixture counted after vigorous shaking.
Tissue radioactivity levels were expressed, as disintegrations per
minute (DPM/mg protein) and corrected, for differential plasma
radioactivity levels by expression as tissue/plasma ratios (DPM/
mg protein: DPM/u1 plasma) for reasons that have previously been
delineated. (McEwen 4 Pfaff, 1970).
In vivo--^-progestin uptake . Techniques for investigating the
uptake and binding of -^-progestins are similar to those used for \-
estradiol with several exceptions. All buffers contained 12 mM
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^„ „^
^^^^^
haveW optical for
.tudyln, the progestin receptor fro. ^a^allan
uterus (Pell. Glasser. Toft
. O-Halley. 1972, PhillWt
. Raynaud. 1973
197^., Toft 4 Sherman. 1975). Also, l^edlately after dissection,
tissues Here placed into homogenizers stored at 4°C.
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SECTION I, INHIBITION OF SFJCUAL BEHAVIOR - THE RAT AS A
HYPOSENSITIVE GUINEA PIG
In guinea pigs, unlike rats, inhibition is usually observed
within broad ranges of doses of estrogens and progesterone. Following
a subcutaneous injection of radioactively labeled progesterone,
guinea pig brains take up more progesterone relative to blood
plasma levels and retain the progesterone for a longer duration than
do rat brains (Wade, Harding & Feder, 1973). If the ambiguity of
progesterone 's antagonistic effects in rats is related, to the lesser
neural uptake and/or retention of progesterone, then the progesterone
dose necessary to inhibit lordosis should, be greater in rats than in
guinea pigs. Perhaps sufficient quantities of progesterone must be
administered to maintain neural progesterone concentrations at
some critical level. In addition, previous work (e.g.. Powers &
Zucker, I969) suggests that there may be a critical relationship
between the level of estradiol sind the level of progesterone administered.
The factors which may influence sequential inhibition have also
not been described for rats. However, with very low doses of estro-
gen priming (Nadler, 1970) or with intrahypothalamic estradiol
implants (Lisk, 1969)1 progesterone may sequentially inhibit in
ovariectomized. rats.
During the estrous cycle, progesterone has been shown to exert
at leaist a minor sequential inhibitory influence on the facilitation
of a subsequent episode of sexual receptivity by progesterone
(powers ic Moreines, 1976). Other reports of both success and failure
(Barfield 4 Lisk, 197^; Powers, 1970; Powers & Moreines, 1976) in
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finding inhibition by progesterone in estrous-cycling rats have
used, a concurrent inhibition procedure. In light of the conflictiiig
evidence for sequential inhibition in ovariectomized. rats (Zucker,
1967a) and in estrous-cycling rats, it is necessary to first
document sequential inhibition by progesterone in OVX rats and then
to characterize the conditions under which it occurs. Only after
we have characterized, progesterone 's involvement in a behavior
can we make predictions of its mechanism of action. In Section I
progesterone 's involvement in both concurrent and sequential inhi-
bition in OVX rats will be characterized.
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EXPERIMENT 1» DAILY INJECTIONS OF PROGESTERa.E AND ESTRADIOL BENZOATS
Charonic daily injections of large doses of progesterone with
EB result in lower levels of sexual receptivity than small doses
of progesterone with EB when tested after 10 days of treatment
(Edwards et al., I968). However in the previous work, only the
effects of chronic injections of the two hormones were investigated.
The first experiment is an attempt to replicate these findings and
extend them to a lower dose of EB and a more typical testing pro-
cedure in which testing occurs 5-7 hours after a progesterone
injection.
Procedure
. Twenty-two ovariectomized. rats were divided into
three groups receiving subcutaneous injections daily of either 2 wg
of EB at 0600 hours (n=0), 2 yiig of EB + 0.5 mg progesterone (n=7) or
2 jug of EB + 5 mg of progesterone (n=6). On Day 10 all rats were
injected with 0.5 nig of progesterone (O8OO hour^ and tested 5-7
hours later for sexual receptivity.
Results . Although high levels of progesterone inhibited the
induction of sexual behavior when compared with the group which
received EB alone, U (6,9) = 0, 2< .005* or the low progesterone
group, U (6,7) = 0, J2 < 'OOSf low doses of progesterone did not
significantly inhibit sexual behavior, U (7,9) = 17.5. 2 < 'lO*
(Figure 1).
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Figure 1. Mean lordosis ratings (- standard error) of ovari-
ectomized rats given daily injections of 2 ug of estradiol benzoate
(EB) alone, 2 Aig of EB + 0.5 mg of progesterone, or 2 /Ug of EB + 5 mg
of progesterone for nine days. (Tests occurred on the tenth day
and were preceded by a single injection of 0.5 mg of progesterone.)
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^HI^IMENT 2: CONCl^RENT INHIBITION
- INFLUENCE OF PROGEST^ONE DOSE
The results of Experiment 1 demonstrated that with chronic
daily injections of progesterone and EB. progesterone in a sufficiently
high dose can antagonize the actions of estradiol in the induction
Of sexual receptivity. In Experiment 2 the effects of various doses
of progesterone administered simultaneously with EB were studied in
a typical induction procedure - a single injection of EB followed
42 hours later by a single injection of progesterone.
Procedure. Thir :y-three ovariectomized rats were divided into
five groups receiving various doses of progesterone or oil. All
rats were injected subcutaneously with 2 ms of EB at 1400 hours.
At this time either oil (n=8). 0.5 mg (n=7), 1 mg (n=6). 2.5 mg
(n=6), or 5 mg (n=6) of progesterone was injected at a separate
subcutaneous site. Forty-two hours later (0800 hours), 0.5 mg of
progesterone was administered, and sexual receptivity was tested
5-7 hours later.
Results. Dosages of 2.5 mg of progesterone and 5 mg of proges-
terone significantly inhibited the induction of sexual receptivity
when compared with rats that received EB + oil,U (6,8) = 3, ^ < .005;
U (6,8) = 1, 2 < .005 (Figure 2). Neither the 0.5 mg progesterone
nor the 1 mg progesterone group was significantly different from the
controls which received EB auid oil.
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Figure 2. Mean lordosis ratings (+ standard error) of
ovariectomized rats treated with various doses of progesterone or
sesame oil simultaneously with 2 ^ig of estradiol benzoate. (All
groups received 0.5 mg of progesterone at 42 hours and were tested
at approximately 48 hours.)
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EXPERIMENT Jt CONCURRENT INHIBITION - TEJIPOP^L DEPENDENCE OF
THE PROGESTERONE INJECTION
Experiment 2 showed that lordosis can be readily inhibited in
a typical induction procedure if a sufficient dose of progesterone
is administered simultaneously with the EB injection. The purpose
of Experiment 3 was to broaden the basis for comparison of the antag-
onistic effects of progesterone on sexual behavior in guinea pigs
and rats. Progesterone was administered at various intervals prior
to the injection of EB in a typical induction procedure to demon-
strate that progesterone caji inhibit estradiol's action when present
temporally close to the EB injection but not if separated by a
longer duration. Doses of the two hormones were chosen (2 yg of EB
and 5 rog of progesterone) that are approximately behaviorally
equivalent to the levels used in a similar experiment with guinea
pigs (Wallen et al., 1975).
Procedure
.
Fifty-four ovariectomized rats were distributed
into groups receiving 5 nig of progesterone at various times prior
to the EB injection. Progesterone was injected subcutaneously either
2 hours (n=9), ^ hours (n=ll), 16 hours (n=8) or 48 hours (n=6) prior
to the injection of 2 wg of EB. The control group (No P; n=15)
received, oil simultaneously with the EB injection. At 42 hours, 0.5
mg of progesterone was injected and emimals were tested 5-7 hours
lateo:. Data for the 0 hour group that received 5 nig of progesterone
simultaneously with the EB injection were tciken from Experiment 2.
Results . When compared with the No P controls, progesterone
injected either simultaneously with EB, U (6,15) ° 4, < '005.
2 hours prior to EB, U (9.I5) = 19. £ < .02, k hours prior to EB,
U (11.15) = ^.5, 2 < .002, or 16 hours prior to EB, U (8,15) =
10.5. 2 < .002, inhibited the action of estradiol in the induction
of sexual receptivity (Figure 3). However, if progesterone was
given 46 hours prior to EB, there was no evidence of inhibition of
lordosis.
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Figure 3. Mean lordosis ratings (+ standard error) of
ovariectoraized rats treated with 5 of progesterone either
simultaneously with or at various intervals prior to 2 >ig of
estradiol benzoate. The No P control group received only an
injection of oil simultaneously with the estradiol benzoate
injection. (All groups were injected with 0,5 mg of progesterone
at k2 hours and. tested at approximately 48 hours.)
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EXPERIMENT 4i CONCURRENT INHIBITION -
BENZOATE DOSE
INFLUirNCE OF ESTRADIOL
The results of Experiment 3 are remarkably similar to those
obtained in guinea pigs with a quite different ratio of the two
hormones (Wallen et al., 1975). It is now quite clear that the
basis for the original failure to observe antagonism by progesterone
of sexual receptivity in ovariectomized rats was due to an insuf-
ficient dose of progesterone (Zucker, 1967a; 0.16 or 1 mg of
progesterone). Since during some stages of pregnarxcy and pseudo-
pregnancy 6 Aig of EB can overcome the antagonism seen with 2 ;ug of
EB (Powers & Zucker, I969), it also seems that the dose of estradiol
is critical. Experiment k tested this hypothesis by varying the
dose of EB while holding the progesterone dose constant.
Procedure
.
Twelve ovariectomized rats were injected with
either 6 /jg of EB (n=6) or 10 Mg of EB (n=6) simultaneously with 5
mg of progesterone. Forty-two hours later, all animals received O.5
mg of progesterone and. were tested for sexual receptivity after 5-7
hours. Data from a group from Experiment 2 that received 2 ug of
EB + 5 mg of progesterone (n=6) were included for comparison.
Results and discussion
. The 10 jug EB group was significantly
different ftora the 2 >ug EB group, U (6,6) = 4, 2 < •05t but the 6 jog
EB group was not, U (6,6) = 10, 2 > .20 (Figure 4).
The results of this experiment demonstrate one more reason for
the lack of positive findings on progesterone antagonism of sexual
receptivity in rats. Increasing the dose of EB can clearly overcome
the inhibition by a particular dose of progesterone (in this case, 5
mg). Some previous research has used 6 Mg EB for the induct!
sexual receptivity (Zucker, 1967a).
k2
Figure Mean lordosis ratings (+ standard error) of
ovariectomized. rats injected with 5 nig of progesterone (P) +
various doses of estradiol benzoate. (Forty-two hours later all
groups received 0,5 mg of progesterone followed approximately 6
hours later by testing.)
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EXPERIMENT 5: CONCURRENT INHIBITION - INFLUENCE OF REPEATED
PROGESTHiONE INJECTIONS
Following a subcutaneous injectk>nof 40 ^Ci of ^H-progesterone
(approximately 6.3 p^), the brains of guinea pigs take up more
progesterone and retain it for a longer period than do rat brains.
Significant levels of progesterone are retained in neural tissues
of guinea pigs in excess of 24 hours after an injection of approxi-
mately 0.3 in rats, progesterone is undetectable by 16 hours. As
already demonstrated., the dose of progesterona requii-ed for con-
current inhibition of sexual receptivity in rats is well in excess
of that required, in guinea pigs (approximately 2.5 rag of progesterone
for 2 «g of EB for rats vs. approximately 0.4 mg of progesterone for
6 jLig of EE in guinea pigs; (Wallen et al., 1975; Zucker, I966).
If the basis for less sensitivity in rats is related to the lack of
maintenance of significant quantities of progesterone in neural
tissues, then the same quantity of progesterone distributed into
multiple injections should, be more effective than a single injection
in inhibiting lordosis. Experiment 5 tests that hypothesis.
Procedure . Eleven ovariectomized rats were divided into two
groups receiving two progesterone treatments in counterbalanced
order. One group first received 1 mg of progesterone at the time of
the EB (2 jjg) injection followed by four oil injections at 4, 8, 12,
and 16 hours. The other group first received 0.2 mg of progesterone
at each of these five injection times for a total of 1 mg of progester
one. At 42 hours, all rats received. 0.5 mg of progesterone followed
5-7 hours later by testing. Eight days later, treatments were
reversed so that each ajiimal served as its own control in a within-
i
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subjects desig;..
Results and discussion. Treatment vdth five injections of 0.2
ng of progesterone resulted in significantly lower levels of lordosis
than a single injection of 1 mg progesterone, T (ll) = 4, ^ < .10.
Wilcoxon, (Figure 5).
These results support the hypothesis that the basis of rats'
hyposensitivity to progesterone is related to their lack of retention
of progesterone in neural tissues. The findings are consistent with
the notion that a function of the large single doses of progesterone
required, to antagonize the induction of sexual behavior in rats might
be to maintain neural progesterone concentrations at some particular
level.
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Figure
-5. Meaii lordosis ratings (+ standard error) of ovari-
ectoniized rats injected with 1 mg of progesterone either in one
injection simultaneously with 2 Aog of estradiol benzoate or in five
injections of 0.2 rag each at 4-hour intervals starting at the same
time as the initial 2 yg of estradiol benzoate. (Forty-two hours
after the estradiol benzoate injection all rats received 0.5 mg of
progesterone followed approximately 6 hours later by testing.)
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EXPERIMEMT 6, SEQUENTIAL INHIBITION - INFLUENCE OF PROGESTERONE
DOGE
It now seems likely that progesterone has some inhibitory
influence on sexual receptivity in estrous-cycling rats (Powers &
Moreines. 1976) as it does in guinea pigs (Goy, Phoenix & Young,
1966). As discussed, in OVX rats, there are reports of both success
(Lisk, 1969; Nadler, 1970) and failure (Zucker, 1967a) to obtain
sequential inhibition of sexual receptivity by progesterone.
Experiments 1-k suggest that concurrent inhibition by progesterone
is critically dependent on the doses of both progesterone and EB. If
concurrent inhibition and. sequential inhibition are caused by a
common neurochemical event, one would expect similar dose-response
relationships for the latter which would explain the previous con-
flicting observations. That is, sequential inhibition might also
require high levels of progesterone with low levels of estradiol. In
Experiment 6 I obtain a dose-response relationship for sequential
inhibition by progesterone using a low priming dose of EB. Tests
occurred. 1 and 2 days after EB injections to ensure, that the neural
substrate would, remain "conditioned" by estradiol for the second
test. The first test (30 hours) is a test of the facilitatory
influence of the particular dose of progesterone and. the second (54
hours) is a test for a subsequent inhibitory influence (sequential
inhibition).
Procedure
. Twenty-nine ovariectomized rats were divided into
five groups. All rats received 2 /Jg of EB at 0 hours. At 24 hours
they received either oil (n«=6), 0.1 mg (n=6), 0.5 mg (n=5), 1 mg
k9
(n=7) or 2.5 mg of progesterone (n=5). Five to 7 hours after
progesterone injections (30 hours), rats were tested for sexual
receptivity. At 48 hours, all animals were given 0.5 mg of progester-
one and tested 5-? hours later (54 hours).
Results and. discussion. Either O.5 mg. 1 mg or 2.5 mg of
progesterone facilitated lordosis at 30 hours, but 0.1 mg of
progesterone did. not (Figure 6).
One mg of progesterone, U (6,?) = 4. £ < .05, and 2.5 mg of
progesterone, U (/f,6) = 2. 2 < .05, indiiced a refractoriness to the
second, progesterone injection, whereas oil, 0.1 mg or 0.5 mg of
progesterone did not, (Figure 6). A lordosis rating could not be
obtained, for the second test of one rat in the 2.5 mg group because
it would, not allow the males to mount.
The results of this experiment indicated that under conditions
of relatively high levels of progesterone, sequential inhibition can
be observed, in rats. It should, be emphasized that although 0.5 mg of
progesterone facilitates sexual behavior at 30 hours, it does not
subsequently inhibit receptivity measured at 54 hours. Thus, the
facilitatory and. ajitagonistic influences of progesterone on
sexual receptivity are dissociable in rats. Unlike the situation in
guinea pigs (Morin & Feder, 1974) a higher dose of progesterone is
required to inhibit sequentially than to facilitate.
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Figure 6. Mean lordosis ratings (+ standard error) of ovari-
ectomized rats injected with oil or various doses of progesterone
24 hours after 2 ^ of estradiol benzoate. Rats were tested 5-?
hours later (30 hour test), administered 0.5 mg of progesterone at
^ hours, and tested again 5-7 hours later (54 hour test).
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EXPEBIMENT 7. SBSUfflTIAL INHIBITION - ABE COPUUTQRY STIMULI
NECESSARY?
The results of Experiment 6 clearly point out that copulatory
stimuli alone are not sufficient to induce the refractoriness to
subsequent progesterone because all of the groups that received low
doses of progesterone also received copulatory stimuli on the first
test, but were not inhibited as measured on the second test. How-
ever, since copulatory stimuli can influence lordosis in a repeated
testing situation (Hardy & DeBold, 1972), Experiment ? was performed,
to deternine whether copulatory stimuli are necessary for the
sequential inhibition.
Procedure. Nineteen ovaxiectomized rats were divided into
three groups receiving various progesterone treatments 2^- hours
after a 2 EB injection. Either oil (n=5), 1 mg (n=9) or 2.5 mg
(n=5) of progesterone was administered at 2k hours, but animals were
not tested at 30 hours as they were in Experiment 1. At 48 hours all
animals received 0.5 mg of progesterone and were tested 5-7 hours
later for lordosis (54 hours).
Results and discussion
.
Both 1 mg of progesterone U (5,9) = 7,
i < .05 and 2.5 mg of progesterone, U (5,5) = 0, ^ < .01, at 24 hours
resulted in a decrease in lordosis when tested at 54 hours (Figure 7).
The results of the last two experiments indicate that under con-
ditions of a relatively low dose of EB (2 Mg), progesterone can se-
quentially inhibit the subsequent display of receptive behavior. It
is clear that copulatory stimuli are neither necessary (Exp^iment 7)
nor sufficient (Experiment 6) for this inhibition.
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Figure ?. Mean lordosis ratings (+ standard error) of ovari-
ectomized rats injected with oil, 1 or 2.5 mg of progesterone 24
hoxirs after 2 iig of estradiol benzoate. (Rats were injected with
0.5 mg of progesterone at 48 hours and tested 5-7 hours later.)
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EXPEHDlm 8. nmBITION
- IN^ENCE OF ^BmoiOL
BEHZOATE DCSE
m Experiment k it was
.hown that concurrent inhibition Is
critically dependent on the dose of EB adininistered
. In Experiment
8 the effects of various doses of EB on sequential inhibition are
compared.,
£EOceise. Ovarlectomized rats
-ere divided into two treatment
groups receiving either 6^ of EB (n=6) or 10 ug of EB (n=6) at 0
hours. At 24 hours all rats were Injected with 1 mg of progesterone
and tested 5-7 hours later (30 hours) for sexual receptivity. At
'»8 hours, all animals received a O.5 mg progesterone injection and
were tested. 5-7 hours later for sequential inhibiticn by the first
progesterone injection. Data ft:om a group which received 2 Hg of EB
at 0 hours (Experiment 6) axe included, for comparison.
Hesults and discussion. Both the 6 jig EB group, u (6,6) = 5,
£ < .05, and the 10 «g EB group U (6,7) = 4.5, £ < .05, were signi-
ficantly different from the 2 ug EB group, (Figure 8). These results
clearly demonstrate that with a sequential inhibition procedure,
increasing doses of EB can offset the antagonism of a particular
dose of progesterone just as with concurrent inhibition.
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Figure 8. Mean lordosis ratings (+ standard error) of ovari-
ectomized. rats injected with 1 mg of progesterone hours after
2 Aig, 6 ug, or 10 ug of estradiol benzoate. Rats were tested
5-7 hours later (30 hour test), administered O.5 mg of progesterone
at 48 hours and tested again 5-7 hour later (54 hour test).
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EXPERIMENT 9: CONCURRENT INHIBITION - 30 HO'JR TEST
In Experiments 6 and ?, 1 mg of progesterone was successful
in antagonizing sexual behavior when tested 30 hours later. In
Experiment 2 which used a concurrent inhibition procedure, 2.5 mg of
progesterone was necessary to inhibit 2 ;ag of EB. There are several
obvious differences between these procedures: l) In the sequential
inhibition procedure, sexual behavior was tested 30 hours after pro-
gesterone; in the concurrent procedure, it was tested 48 hours after
the inhibitory progesterone injection. 2) Although plasma estradiol
levels were not measured in these experiments, in the period after
the sequential progesterone injection, estradiol levels were probably
lower than after the concurrent progesterone injection (Cheng &
Johnson, 1974; Tapper, Greig & Brown-Grant, 1974). 3) At the time of
the sequential injection, estradiol had. been present in neural tis-
sues for 24 hours; at the time of the concurrent injection, it was
not yet present.
The purpose of Experiment 9 was to determine whether 1 mg of
progesterone induces a transient inhibition that can be observed
when tested 30 hours after the injection but not after 48 hours. This
would, perhaps, account for the dose differences in sequential and
concurrent inhibition. Steroids were injected in a concurrent
procedure and testing occurred at 30 hours rather than at 48 hours
as in Experiment 2.
Procedure
. Twenty-eight ovariectomized rats were injected with
2 >ig of EB at 0 hours euid. received either an injection of 1 mg of
progesterone (n='l4) or the oil vehicle (n«=l4) simultaneously. At 24
38
hours, all rats received a 0.5 mg progestero-.e injection and were
tested 5-7 hours later for sexual behavior.
Results and discussion. The group which received progesterone
concurrently with EB displayed a mean lordosis rating of I.33 + 0.23;
the oil control exhibited a mean lordosis rating of I.69 + 0.20.
This difference is not statistically significant, and the difference
is actually slightly less than that for rats tested at 48 hours
(Experiment 2). Experiment 9 was unsuccessful in demonstrating a
transient inhibition with 1 mg of progesterone in a concurrent in-
hibition procedure when testing occurred, at 30 hours. However, in
the period after the concurrent injection, estradiol levels were
probably considerably higher than after the sequential injections
(Experiment 6). Since Experiments 4 and 8 have already demonstrated
the importance of EB dose in both concurrent and sequential inhibition,
it is perhaps not surprising that this dose of progesterone did not
result in inhibition.
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DISCUSSION
:.erone
These studies offer unequivocal evidence that progost(
antagonizes estradiol's induction of sexual behavior in ovariectomized
rats using both chronic and single injections. Although there are
clearly differences between rats and guinea pigs in the dose of
progesterone required for concurrent inhibition, the phenomenon
seems to be as robust in rats as in guinea pigs.
There are at least two obvious reasons for the previous negative
results of experiments on concurrent inhibition by progesterone in
ovariectomized rats (Zucker, 1967a). First, as Experiment 2 demon-
strated, with the dose of EB held constant at 2 Mg, approximately
2»5 mg of progesterone is required, for concurrent inhibition when
tested at HQ hours. In addition, the inhibition is dependent on the
EB dose as well; six or 10 ^ EB can offset the antagonistic in-
fluence of 5 mg progesterone. In earlier work (Zucker, 1967a) only
1 mg of progesterone with 6 Mg of EB was used.
Perhaps the basis for the species difference in sensitivity to
progesterone is the difference in neural retention between rats and
guinea pigs. Progesterone is taken up into guinea pig brains in
greater concentrations than in rat brains, and it is retained there
for a longer period of time (Wade et al., 1973). Experiment 5 was
designed to prevent progesterone levels from rapidly waning. One rag
progesterone, which does not significantly inhibit the induction of
lordosis when administered concurrently with 2 wg of EB, wcis dis-
tributed into 5 injections spaced at 4-hour intervals. This treat-
ment resulted in a 45^ decrease in lordosis ratings when tested at
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48 hours, confirming the prediction based on the species difference
in neural progesterone retention. It suggests that a function of the
higher dose of progesterone necessary for concurrent inhibition in
rats is to maintain progesterone levels at some critical value. These
results also suggest that the initial levels of progesterone are less
important for the inhibition than is the maintenance dose. That is,
the low initial dose of progesterone (0.2 mg) resulted in greater
inhibition than the high dose (l mg) when the low levels were main-
tained for l6 hours by frequent injections.
Sequential inhibition is also as robust a phenomenon in rats
as in guinea pigs. Just as with concurrent inhibition, species
dissimilarities seem to be dose-dependent. Rats seem to be less
sensitive to progesterone 's sequentiail inhibitory influence than
guinea pigs.
It is clear that the sequential inhibition measured at 5^ hours
is not a result of copulatory stimuli obtained on the 30-hour test.
Copulatory stimuli are obviously not sufficient for the refractoriness,
because in Experiment 6 all rats received copulatory stimuli but the
sexual behavior of only the 1 mg and 2.5 mg progesterone groups
was inhibited. In fact, the 0.5 mg progesterone group showed high
levels of receptivity on the30-hour test but was not inhibited when
tested at 54 hours. Also, the results of Ebcperiment 7 indicate that
copulatory stimuli are not necessary for the inhibition; high doses
of progesterone inhibited sexual behavior tested at 54 hours even
in the absence of the 30-hour test. Thus, this sequential inhibition
is clearly the result of high doses of progesterone.
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increasing the EB dose offset t.e sequential inhibition
resulting f^om a particular dose of progesterone with concurrent
inhibition. Thus this inhibition is dose-dependent. both on
progesterone and on estradiol. These results help to explain the
previous conflicting reports of progesterone-induced refractory
period m ovariectomized rats. Previously, Lisk (I969) used hypo-
thalamic implants of estradiol and. Nadler (1970) used two daily
injections of 1 EB. Both of these techniques resulted in moderate
inhibition by progesterone. Zucker (1967a). on the other hand, used
a large (6^) EB priming dose which did not result in sequential
inhibition. The results of Experiment 8 are consistent with the
previous reports and. help to explain the basis for the inconsistencies.
The results of these experiments also suggest that concurrent
inhibition may not be biochemically distinct from sequential inhibition.
Although sequential inhibition has been defined as inhibition that
occurs after estrogen conditioning is complete (Powers & Moreines.
1976), there is, as yet no reason to assume that in ovariectomized.
rats, these are anything but procedural distinctions. Both classes
of inhibition are dose-dependent on progesterone and. estradiol. The
difference seems to be dose-dependent with more progesterone re-
quired for concurrent than sequential inhibition. This, as already
pointed, out, is likely due to differences in plasma levels of estra-
diol subsequent to the progesterone injection.
In a concurrent inhibition paradigm, a dose of approximately
2.5 mg progesterone is necessary to inhibit the induction of sexual
receptivity by 2 /Ug EB. Experiment 6 demonstrates that as little as
1 mg progesterone injected at 2^ hours can inhibit lordosis sequen-
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tially when tested at ^ ho^^s. In the concurrent procedure. 48
hours elapse between the inhibitory progesterone injection and.
testing; in the sequential procedure, only 30 hours elapse. Since
Zucker (1966) had. shown in guinea pigs that both concurrent and
sequential inhibition axe transient. I attempted to determine if this
dose difference is due merely to the longer delay between the inhibi-
tory progesterone injection and. testing in the concurrent procedure.
Experiment 9 tested for concurrent inhibition by 1 mg of progesterone
at 30 hours rather than at 48 hours. This dose of progesterone actu-
ally inhibited slightly less than when tested, at 48 hours. In the
period following the sequential progesterone injection (24 hours) the
plasma levels of estradiol were presumably lower than after the con-
current progesterone injection (O hours; Cheng & Johnson, 1975;
Tapper et al., 1974). We know that estradiol levels are critically
involved since increasing doses of EB can offset the inhibition by a
particular dose of progesterone in either the concurrent or sequential
inhibition procedure.
The physiological role of progesterone 's concurrent inhibition
in rats is not known. Concurrent inhibition may occur during the
estrous cycle of the rat (Barfield & Lisk, 1974; but cf . Powers &
Moreines, 1976). However, it has been suggested that progesterone 's
inhibitory influences during the estrous cycle should, be sequential,
not concurrent, simply because there are minimal levels of progesterone
in the circulation during estrogen priming in the normal estrous cycle
(Powers & Moreines, 1976). Although it is instructive to distinguish
between procedures that are designed, to investigate sequential inhibi-
tion, the two classes may not be biochemically distinct.
LOT
'S
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SECTION II, S-.IITHETIC ESTOOGEN ANTAGONIST AS A MODEL OF INHIBITION
Although progesterone potentiates estradiol's effects on nest-
building in ovariectomized mice (Lisk, 1971) and sexual behavi
in rodents (Feder & Marrone, 1977; Morin, 1977), progesterone
Influence on other behaviors is limited to antagonism of estradiol's
effects. Progesterone inhibits estradiol's induction of sexual
behavior (Feder & Marrone, 1977; Morin. 1977), running-wheel acti-
vity (Rodier, 1971; Wade, 1976) and maternal behavior (Siegal &
Rosenblatt, 1975), and estradiol's suppression of eating behavior
(Wade, 1975. 1976).
Recently, evidence has accumulated that the cell nucleus is
the site of action for estradiol's effects on behavior (McEwen,
1975; McEwen, Denef, Gerlach & Plapinger, 197^). After an injection
of H-estradiol the greatest concentration of the radioactivity which
accumulates in brain cells is found in purified cell nuclei (Zigmond,
1975; Zigmond & McEwen, 1970). Inhibitors of transcription (Ho,
Quadagno, Cooke & Gorski, 1973; Hough, Ho, Cooke & Quadagno, 197^;
Quadagno, Shryne & Gorski, 1971; Whalen, Gorzalka, DeBold, Quadagno,
Ho & Hough, 197^) or translation (Quadagno & Ho, 1975) reversibly
inhibit the induction of sexual behavico: when implcinted into the
preoptic area in temporal proximity to aji injection of estradiol.
Compelling evidence that the cell nucleus is a site of action
for estradiol derives from work with synthetic estrogen ajitagonists
.
These are compounds that prevent the full response of a tissue to an
estrogen (Clark, Anderson & Peck, 1973; Katzenellenbogen 4 Ferguson,
1975) • III the rat brain, these compounds deplete cytoplasmic
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estrogen receptors (Whalen. Martin & Olsen, 1975). compete with
estradiol for estrogen receptors (Whalen et al.
, 1975). delay
replenishment of estrogen receptors (Whalen et al., I975), inhibit
the uptake of ^H-estradiol into brain cell nuclei (Chazal, Faudon.
Gogan & Rotsztejn, 1975; Landau. 1977; Luine & McEwen, I977. Luttge,
Gray & Hughes. I976; Roy & Wade, 1977). and displace tritium,
presumably bound ^estradiol from cell nuclei (Landau, I977. Roy
& Wade, 1977). Synthetic estrogen antagonists that are effective in
inhibiting the induction of sexual behavior by estradiol followed by
progesterone also decrease the uptake and retention of radioactively
labeled estradiol by cell nuclei of neural target tissues (Landau,
1976, 1977; Roy & Wade, 1977) offering further support for a nuclear
site of action.
One possible biochemical mechanism that might account for the
inhibitory effects of progesterone could be a decrease in cell
nuclear binding of ^H-estradiol in neural estrogen target tissues.
Although, using autoradiography, Anderson and Greenwald (I968) have
reported a decrease in estrogen uptake in hypothalamic cells, pro-
gesterone does not compete vrith estradiol for estrogen receptors in
brain or pituitary in vitro (Chader & Villee, 1971; Davies, Siu,
Naftolin & Ryan, 1975; Eisenfeld, 1970; Vertes & King, 1973).
Progesterone also does not inhibit the rate of formation of estrogen-
receptor complexes in pituitary (Korach & Muldoon, 1975), nor inhibit
the replenishment of estrogen receptors in the hypothalajnus or
preoptic area (DeBold, Martin & Whalen, 1976; Pavlik & Coulson,
1976) as in the uterus (Hsueh, Peck & Clark, 1975, 1976).
The synthetic estrogen antagonist CI
-628, is one antagonist that
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Inhibits the induction of rat sex^l behavior (Aral 4 Gorskl, I968,
Powers, 1975i Whalen 4 Gorzalka, 1973) and decreases the binding of
^H-estradlol by brain cell nuclei (Chazal et M.. 1975; Landau, I977
Luttge, Gray 4 Hughes, 1976, Roy 4 Wade, 1977). In Section II. an
attempt is n^de to alter cell nuclear binding of ^H-estradiol through
the use of estrogen antagonists, progesterone and CI-628, using
sexual behavior as a model.
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EXPERIMENT lOj EFFECTS OF PROGESTERONE ON R'TENTION OF ^H-
ESTOADIOL BY BRAIN CHILL NUCLEI
With autoradiographic techniques, it has been reported that
uptake of radioactively labeled estradiol into hypothalamic cells
can be inhibited by pretreatment with 2.5 mg of progesterone (Anderson
& Greenwald, I969). The present experiment attempted to alter re-
tention of estradiol in cell nuclei of neural areas believed to be
involved in sexual behavior in female rats (Lisk, I969; Powers, 1972;
Powers & Valenstein, 1972) by pretreatment with a large quantity of
progesterone. The biochemical techniques used are identical to those
in which synthetic antiestrogens have been shown to inhibit the
uptake and retention of "^H-estradiol in brain cell nuclei (Roy &
Wade, 1977).
Procedure. Fourteen female rats ovariectomized at least 2 weeks
previously and weighing 250-300 g at the time of sacrifice were used.
Six rats received a 10 mg intraperitoneal injection of progesterone
fO.2 ml) and eight rats received the sesame oil vehicle, followed 2
hours later by an intravenous injection of 100 juCi (O.3 /dg) of
2,4,6,7-^H-estradiol-17^(specific activity: 91.3 Ci/mmole; New England
Nuclear, Boston, Mass.) in 20^ ethanol-saline
. Twelve hours after the
3
-^H-estradiol injection rats were sacrificed as described. The brain
was dissected into cerebral cortex (120 mg), preoptic area-septum
(60 mg), and hypothalamus (60 mg). The cortex included frontal and
parietal cortex without white matter; the preoptic area-septum
included the anterior hypothalamus, preoptic area, bed nucleus of the
stria terminalis, and septum. The hypothalamus was bounded by the
67
«a„™inary bodies, hypothalamic fl.sures and caudal edge of the optic
Chiasma. extending dorsally 3 The entire pituitary gland was
also taken.
Results. The 10 n.g injectiai of progesterone was without
effect on the 12-hour retention of ^-estradiol, (Figure 9).
None of the comparisons of tissue/plas.a levels of progesterone vs.
oil groups for the whole homogenate or nuclear fractions of the
four tissues approached statistical significance. In fact, for all
tissues, tissue/plasma ratios are quite similar for the two groups.
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Figure 9. Retention of ^H-estradiol in brain areas and pituitary
12 hours after an intravenous injection of 100 ^Ci ^H-estradiol.
Either 10 mg progesterone or oil was injected intraperitoneally 2
hours prior to estradiol. (CTX, cerebral cortex; HTH. hypothalamus;
POA, preoptic area-septumj PIT, pituitary gland).
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EXPERIMENT 11, EFFECTS OF ESTOOGEN ANTAGONISTS ON ^H-ESTRADIOL
BINDING
The results of Experiment 10 gave no hint of progesterone
inhibition of nuclear retention of ^estradiol. However, the \.
estradiol was administered intravenously and the progesterone intra-
peritoneally. In an effort to use a procedure with more behavioral
relevance, in the next experiment the steroids were administered in
a manner that is known to result in behavioral inhibition, that is,
subcutaneously (Section l). In addition, to optimize the possi-
bility of observing inhibition if it exists, a very large quantity
of progesterone was injected (lO^-fold excess). A comparison is also
made with inhibition by an injection of CI-628.
Procedure. Fifteen rats ovariectomized approximately two weeks
previously and weighing I9O-26O g were used. Five rats were injected
subcutaneously with 30 mg of progesterone (0.6 ml), five with k mg
CI-628 (0.6 ml) and five with the sesame oil vehicle (0.6 ml).
Within seconds, 100 uCi of ^estradiol dissolved in 0.2 ml sesame
oil was injected subcutaneously. Due to the large volume of the
injections, the progesterone and oil were injected into two separate
sites, each consisting of O.3 ml, and the -^H-estradiol was injected
to a third site. Four hours later, animals were sacrificed, tissues
dissected, and radioactivity counted as described. In this experiment,
the hypothalamus and preoptic area sections were pooled and a sample
of midbrain taken (approximately 60 mg), since cannula implants of
progesterone in this area affect receptive behavior (Morin & Feder,
1974c; Ross, Claybaugh, Clemens & Garski, 1971). The midbrain sample
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was immediately caudal to the hypothalajuus and included the peri-
aqueductal region of estradiol-concentrating cells described by
Pfaff and Keiner (1973).
Results and discussion. As in the previous experiment, compari-
sons of the progesterone vs. oil groups for the whole homogenate
and nuclear fraction of each tissue revealed that the progesterone
treatment was without effect on the uptake of -^H-estradiol, (Table
1). CI-628, however, caused statistically significant inhibition of
cell nuclear binding in hypothalamus, {27%) and pituitary gland (88?^),
but not in cortex or midbrain. CI-628 was effective in the whole
homogenates of all areas. These data support the suggestion that
progesterone 's neural mechanism of cuitagonism of estradiol's
influences is not to inhibit the binding of estradiol by brain cell
nuclei
.
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EXPERH-IENT 12: SEQUENTIAL INHIBITION BY raCGESTERONE AND CI-628
The synthetic antiestrogen. CI-628 inhibits the uptake and
retention of ^H-estradiol in hrain cell nuclei (Roy &Wade. I977.
Exp. 11), whereas even unusually large doses of progesterone (IO-30
mg) do not (Experiment ll). using identical techniques. Progesterone
administered either before or after estrogen conditioning is complete,
is capable of inhibiting the subsequent induction of sexual receptivi-
ty. The antiestrogen, CI-628 has been shown to significantly inhibit
the induction of sexual behavior when injected approximately concur-
rently with EB (Aral & Gorski, I968; Landau, I976; Powers, 1975;
Whalen & Gorzalka, 1973). In Experiment 12 the effects of the syn-
thetic estrogen antagonist, CI-628, and the natural estrogen antagonist,
progesterone, were compared, by administering each in a sequential
inhibition procedure. Each compound was administered after rats had
been screened for lordosis at 30 hours.
Procedure. Ovariectomized rats were injected with 2 ug of EB
followed 24 hours later by O.5 mg of progesterone and were tested
for lordosis at 29-31 hours. At this time, only rats in heat were
selected, and. distributed into three closely matched groups, (Fig-
ure 11). One group (n=5) received 4 mg of CI-628 intraperitoneally
in 0.4 ml saline. The progesterone group (n=9) received an additional
2 mg of progesterone subcutaneously and the control group (n=5)
received O.5 mg of progesterone and were tested for lordosis 5-7 hours
later (54 hours). Since some animals showed a high frequency of
rejection of the males, lordosis ratings are based upon five mounts
far each rat.
7^
Results. Two mg of progesterone after the first test inhibited
the subsequent induction of sexual receptivity by a O.5 mg progester-
one injection at 48 hours. U (5.9) = 7. <
.05. The CI-628 also
antagonized the subsequent facilitation by progesterone at 48 hours,
U (5,5) = 0. 2 < .01 (Figure lO).
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Figure 10. Mean lordosis ratings (+ standard error) of
ovarlectomlzed rats injected with 2 Jig of estradiol bonzoato (O hours),
0,5 mg of progesterone (24 hours), tested for sexual receptivity at
approximately 30 hours and Injected with either saline, 4 mg of CI-
628 or 2 mg of progesterone after behavioral testing. (All rats
received 0,5 mg of progesterone at ^ hours and were retested 5-7
hours later.)
ONIlVd SlSOOdOn NV31AI
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EXPERir4ENT 13» RAPID ANTAGONISM OF SEXUAL BEHAVIOR BY ESTOOGEN
ANTAGONISTS
The results of Experiment 12 demonstrate that CI-628 can inhibit
sequentially just as progesterone. Thus both synthetic and natural
antiestrogens can antagonize receptive behavior not only in a con-
current inhibition paradigm (Powers, 1975) but also after estrogen
conditioning has been completed. Feder and Morin (19?^) have shown
that in guinea pigs, the estrogen antagonist, MER-25 is capable of
blocking the inducticn of sexual receptivity when administered at
about the time of the facilitatory progesterone injection. In
Experiment 12 the behavioral effects of the two classes of estrogen
antagonist were dissociated by administering the CI-628 or a large
dose of progesterone near the time of testing. To optimize the
possibility of detecting inhibition, a dose of 1 yg of EB was used in
this experiment. Since preliminary data had shown that there is no
effect on lordosis as long as 10 hours after treatment with CI-628,
testing occurred, at 13-1^ hours after treatment.
Procedure
.
Fifty ovariectoraized rats were divided into three
groups receiving various treatments 2^ hours after a 1 jog of EB
injection. Rats were injected with either 0.5 mg of progesterone +
0.4 ml of saline (n=18), 5 mg of progesterone + OA ml of saline
(n=ll) or 0.5 mg of progesterone + 4 mg of CI-628 (n=2l) and tested
13-14 hours later for lordosis. Progesterone was injected subcutane-
ously; the CI-628 (dissolved in 0.4 ml of saline) and saline were
injected intraperitoneally.
Results and discussion . Addition of the synthetic estrogen
78
antagonist inhibited sexual receptivity tested IJ^lk hours later when
compared, with the group that received only O.5 mg of progesterone,
U (18,21) = 122.5. £ < .05 (Figure ll). The group that received
5 mg of progesterone actually displayed higher levels of lordosis
than the group that received O.5 mg of progesterone.
These results indicate that administration of an estrogen
antagonist can decrease receptivity when given at the time of the
facilitatory progesterone injection and tested 13-1-!^ hour later,
even a high dose of progesterone at this time cannot. These results
again suggest a different neural mechanism of antagonism for pro--
gesterone than the synthetic estrogen antagonist, CI-628.
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Figure 11. Mean lordosis ratings (+ standard error) of ovari-
ectomized rats injected with either 0.5 mg of progesterone, 5 mg of
progesterone or 0.5 mg of progesterone + ^ mg of CI-628, 2k hours
after a 1 ;ig of estradiol benzoate injection. (Testing occurred
13-14 hours later.)
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DISCUSSION
Roy and Wade (197?) have reported that synthetic estrogen
antagonists that inhibit the induction of sexual behavior also de-
crease the uptake and retention of ^H-estradiol in brain cell nuclei.
The results of Experiment 10 demonstrate that there is no decrease in
retention 12 hours after ^H-estradiol injections in rats pretreated
with 10 mg of progesterone. This stands in contrast to results
using synthetic antagonists. Experiment 11 was performed, to examine
a more behaviorally-relevant mode of administration of the steroids.
An unusually large dose (30 mg) of progesterone or 4 mg GI-628 was
administered subcutaneously and concurrently with a low dose of \-
estradiol in sesame oil. Although CI-628 inhibited nuclear binding
in hypothalamus and. pituitary, none of the progesterone vs. oil
comparisons of k hour uptake approached statistical significance.
Marrone and Feder (197?) have also failed to inhibit brain ^H-
estradiol uptake in guinea pigs with progesterone pretreatment. The
lack of striking inhibition by CI-628 is likely referrable to its
slow action when administered subcutaneously (Landau, 1977).
Experiments 12 and I3 were designed to contrast behaviorally
the inhibition of sexual receptivity by progesterone and the syn-
thetic antiestrogen, CI-628. A potent antagonist of estradiol in
the induction of sexual receptivity (Aral & Gorski, I968; Powers,
1975; Roy & Wade, 1977; Whalen & Gorzalka, 1973), CI-628 also in-
hibits the uptake (Chazal et al., 1975; Landau, 1977; Luine & McEwen,
1977; Luttge et al., I976; Roy & Wade, 1977) of ^estradiol into
cell nuclei (Roy & Wade, 1977). Since large doses of the natural
antiestrogen, progesterone, did not interfere with the uptake
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or retention of ^H-estradiol in hrain cell nuclei with the same
procedures that were successful with CI-628 (Roy & Wade, 19??), an at-
tempt was made to dissociate the behavioral effects of the antagonists
as well. In Experiment 12, CI-628 or progesterone was administered
after a test for sexual receptivity at 30 hours. Both CI-628 and.
progesterone, when administered at 30 hours, inhibited sexual recep-
tivity tested at 54 hours . In Experiment I3 the two classes of
antiestrogen were dissociated behaviorally by administering a high
dose of progesterone or CI-628 13-1^1 hours prior to testing. In
this case only the synthetic antiestrogen inhibited the induction
of sexual receptivity. Thus, the antiestrogenic influences of
progesterone seem to be dissociable from those of the synthetic
antiestrogens on the behavioral level as well as on the biochemical
level
.
The results of Experiment I3 are relevant to an interpretation
of estradiol's role in the induction of sexual receptivity. Some
reports (Bullock, 1970; McEwen, Pfaff
,
Chaptal & Luine, 1975) have
suggested that estradiol has only a triggering function in the in-
duction of sexual receptivity. That is, it perhaps enters the cell
nucleus (McEwen, 1976; McEwen et al. , 1975) and stimulates RNA
synthesis (Quadagno, Shryne & Gorski, 1971 « Terkel, Shryne &
Gorski, 1973; Whalen et al., 197^). They have suggested that estrar
diol need not be retained for the entire duration of estrogen
conditioning. In guinea pigs, howerver, the antiestrogen MER-25
is capable of inhibiting sexual behavior when administered at about
the time of the progesterone injection (Feder & Morin, 197^). In
rats, Whalen and Gorzalka (1973) have demonstrated inhibition when
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* wade. 1977). demonstrated that 01-628 injected at I3-14 hours
prior to testing can inhibit sexual behavior. Landau (1977) has
also demonstrated that CI-628 injected 21 hours after ^H-estradiol
benzoate results in diminished nuclear radioactivity 3 hours later
These results offer support for the interpretation that conditioning
13 an ongoing process which requires sustained estrogen presence
(Feder 4 Morin. 197ifj Feder & Silver. 1974).
SECTION III, PROGESTERONE- S MECHANISM OF AC'^'IONi USE OF A
SYNTHETIC PROGESTIN
Early experiments that investigated a nuclear site of action
for progesterone or binding of progesterone to cytoplasmic receptors
in the mammalian uterus were hampered by the technical limitations
inherent in studying a relatively weak interaction of a hormone with
its receptor. Along with other recent technical advances, the
steroid 17<<, 21-dimethyl-19-nor-pregna-4,9-diene-3,20-dione (R 5020)
has been synthesized. This synthetic progestin bi:.ds specifically
to progestin receptors with high affinity and dissociates less
rapidly than progesterone itself (Philibert & Raynaud, 1973; 197^).
In uterine cytosol it binds to receptors with an association
constant 2-5 times that of progesterone. It binds to the same number
of sites as progesterone supporting the notion that it binds only
to progestin receptors (Philibert & Raynaud, 1973; 197^; Walters &
Clark, 1976). R 5020 is physiologically quite active, 200-300 times
as active as progesterone in standard uterine bioassays for progestins
(Philibert & Raynaud, 1973), a fact consistent with its higher affinity
for progestin receptors. The unique binding characteristics of R 5020
have proven useful in characterizing the binding of progestins to
cytoplasmic receptors in tumorous and reproductive tissues of various
species (McGuire, Raynaud & Baulieu, 1977).
On the basis of experiments which have investigated binding-
activity relationships of steroid hormones (Raynaud, 1977). it can
be Inferred that if binding is involved in behavioral responses, then
a progestin that binds to progestin receptors with higher affinity
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than progesterone should be more active in affecting sexual behavior.
The activity of R 5020 in facilitating and inhibiting sexual behavior
is tested in Experiments 14 and 15 . In the final two experiments,
nuclear binding of Vr 5020 is investigated and contrasted with
that of
-^-progesterone.
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EXPERIMENT 14, FACILITATION AND SEQUENTIAL INHIBITION BY R 5020 -
COMPARISON WITH PROGESTERONE
The purpose of Experiment 14 is to determine the relative ef-
fectiveness of R 5020 compared with progesterone in the facilitation
and sequential inhibition of female sexual behavior.
Procedure. Ninety-two ovariectomized rats were divided into
ten groups. All rats received 2 Mg of EB at 0 hours. At 24 hours,
they received either oil (n=13). 1 Aog of R 5020 (n=5), 2.5 ;ag of
R 5020 (n=10), 5 ^ of R 5020 (n=ll). 10 ^ of R 5020 (n=8),
25 ;ig of R 5020 (n=10), 100 jug of progesterone (n=10). 250 ^g of
progesterone (n=8), 500 ;ag of progesterone (n=10), or 1,000 ng
of progesterone (n=8). Five to seven hours later (30 hours), rats
were tested for sexual receptivity. At 48 hours, all rats were
administered O.5 mg of progesterone and tested five to seven hours
later (54 hours).
Results. As little as 5 ;ag of R 5020 significantly facilitated
sexual behavior at 30 hours when compared with oil controls, U (11,13)
= 7.5. 2 < '002, compared with 250 needed for progesterone, U (8,13)
= 17,
_B < .02, (Figure 12).
As low a dose as 10 ^g of R 5020 sequentially inhibited sexual
behavior at 30 hours, U (8,13) = 24, ^ < 'OS. compared with 1,000
iig needed for progesterone, U (7,13) = 6.5, 2 < -002, (Figure 12).
87
Figure 12. Mean lordosis ratings of ovariectomized rats
injected with various doses of R 5020 (top panel) or progesterone
(bottom panel), or sesame oil vehicle 24 hours after 2 xig of
estradiol benzoate. Rats were tested 5-7 hours later (30 hour test-
facilitation). All rats received O.5 mg of progesterone at 48 hours
and were tested again 5-? hours later (54 hour test-inhibition).
(All steroids were dissolved in 0.1 ml of sesame oil and were
injected subcutaneously.)
FACILITATION AND SEQUENTIAL INHIBITION OF
SEXUAL BEHAVIOR BY R 5020 & PROGESTERONE
mmmm 15, concument inhibition by r 5020 - comparison wi™
PROGESTERONE
The purpose of Experiment I5 is to further characterize R 5020 's
inhibitory effects by investlgati,^ its relative effectiveness in
concurrent inhibition.
^:ocedis:e. Forty-eight ovariectomized rats were divided into
eight groups receiving various doses of R 5020, progesterone or oil
concurrently with EB. All rats were injected with 2 ^g of EB at
1^0 hours. At this time either oil (n=6), 5 of R 5020 (n=6),
10 iig of R 5020 (n=6), 25 Mg of R 5020 (n=6), 50 ;ug of R 5020 (n=6),
1.000 ^ of progesterone (n=6), 2,500 )xg of progesterone (n=6). or
5,000 ng of progesterone (n=6) were injected at a separate sub-
cutaneous site. Forty-two hours later (0800 hours), 0.5 rag of
progesterone were administered, and sexual receptivity was tested
five to seven hours later.
Results and discussion
.
As little as 50 /Ug of R 5020 inhibited
sexual behavior compared with oil controls, U (6,6) = ^, ^ < .05,
(Figure 13). 2,500 jug of progesterone were required for inhibition,
U (6.6) = 1, 2 < .005 (Figure I3).
Thus, R 5020 is 5O-IOO times more effective than progesterone
as both a facilitator and inhibitior of sexual behavior. This
lends support to the hypothesis that progestins' effects on behavior
are mediated by a receptor mechanism as uterine effects may be.
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Figure I3. Mean lordosis ratings of ovariectomized rats in-
jected with various doses of R 5020, progesterone or sesame oil
vehicle simultaneously with 2 ;ag of estradiol benzoate. All rats
received O.5 mg of progesterone at kZ hours and were tested at
approximately 48 hours. (All steroids were dissolved in 0.1 ml of
sesajne oil and were injected subcutaneously.
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RATS
As previously aisoussed, R JOZO's unique Mnding characteristics
have .aae It a useful tool In the study of uterine progestin receptors
Experiments 14 and I5 are consistent with the interpretation that
progestins' behavioral effects axe receptor-mediated. In this ex-
periment, an attempt is made to observe binding by brain cell nuclei.
using ^H-R 5020.
^ocedi^e. Female Sprague-Dawley rats weighing 150-220 grams
were ovariectomized and adrenalectomized and injected daily ^^th 2 ^
of EB for six to eight days. To determine the effects of estrogen
priming, EB was omitted in one group (unprimed; n=4), and the rats
received sesame oil vehicle injections. To demonstrate saturability
and progestin-specificity of the binding, primed rats were injected
'
mtraperitoneally with 1 mg of unlabelled R 5020 (n=4), progesterone
(n=4), corticosterone (n=5), testosterone (n=k)
, or the ethanol
vehicle (n=6), 75 minutes prior to sacrifice. Sixty minutes prior to
sacrifice, all rats were injected intravenously with 20 uCi 6,7 \-
R 5020 (0.1 pg. specific activity = 56.5 Ci/mmole) dissolved in 20fo
ethanol-saline. Pituitary gland, cerebral cortex, preoptic area-
septum and hypothalamus described previously were then dissected.
The sample of midbrain (70 mg) which extended 3 mm caudal to the
hypothalamic sample was bordered dorsally by the posterior commissure
and vertically by the pons. Uterus (120 mg) was minced, homogenized
in a ground glass homogenizer, and filtered through two layers of
gauze
93
Results. The pattern of uptake in whole homogenates of the
estrogen-pri.ed rats was uterus > pituitary > midbrain > hypothalamus
-
preoptic area-septum > cortex. Neither estrogen priming nor com-
peting steroids had any effect on whole homogenate uptake in neural
tissues. However, estrogen priming doubled uptake in uterus and
quadrupled uptake in pituitary. Either R 5020 or progesterone pre-
treatment in estrogen-primed rats decreased whole homogenate uptake
in uterus and pituitary by 59-89f.. Testosterone and corticosterone
were less effective competitors than the two progestins.
The pattern of binding in cell nuclei was considerably different
from whole homogenates, probably owing to the extensive amount of
nonspecific, nonsaturable uptake of progestins in whole homogenates
of neural tissues: uterus > pituitary > hypothalamus > preoptic area-
septum = cortex > midbrain (Fig. Ik). Omission of estrogen priming
resulted in an approximately 8^% decrease in nuclear binding by
hypothalamus, preoptic area-septum, uterus and pituitary, a small
decrease in cortex, but no statistically significant charge in mid-
brain, R 5020 pretreatment suppressed nuclear binding in hypothalamus,
preoptic area-septum, pituitary and uterus to approximately the
levels of unprimed rats. Progesterone was nearly as effective as R
5020 as a competitor. Both progestins were significantly more ef-
fective competitors than either testosterone or corticosterone. The
competition that was obtained with testosterone and corticosterone
is likely due to having used, a very large dose of competitor (l mg)
compared with the -^H-R 5020 (0,1 iJg),
9^
Figure 14. Binding of -'H-R 5020 or its metabolites in brain,
pituitary, and uterine cell nuclei of ovariectomized-adrenal-
ectomized female rats one hour after intravenous injection of 20
juCi of ^H-R 5020, Controls (n=6) received daily injections of 2 ug
of estradiol benzoate for 6-8 days as did the groups which received
1 mg of R 5020 (n=4), progesterone (n=4), corticosterone (n=5) or
testosterone (n=4) 75 minutes prior to sacrifice. Unprimed rats
(n=4) received daily oil injections. Results are expressed as
tissue/plasma ratios of DPM/mg protein: DPM/jil plasma.
vwsvid/3nssii
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EXPERIMENT 1?. ^PROGESTERONE UPTAKE IN OVARIECTOMIZED-ADRENAL-
ECTOMIZED, ESTROGEN-PRIMED RATS
Although previous experiments in guinea pigs (Marrone & Feder,
1977) and rats (McEwen et al., I976) have failed to detect nuclear
binding of ^H-progesterone using liquid scintillation counting
techniques, none of these experiments have used identical procedures
to those which were used in Experiment 16. Experiment 1? is an
attempt to verify either the presence or absence of radioactivity in
brain cell nuclei after injection of ^H-progesteror.e.
Procedure. The procedure is the same as that followed in
Experiment I6 except that rats were injected with 1,2-^H-progesterone
(Specific activity = 55.7 Ci/mmole; New England Nuclear). One
group (n=6) received the ethanol vehicle 75 minutes prior to sacrifice
and one group received 1 mg of unlabelled progesterone (n=4).
Results. The small amount of radioactivity that was found in
cell nuclear fractions was not saturable as evidenced by the failure
of 1 mg of progesterone to compete for binding (Table II). In whole
homogenates, only the uterus specifically accumulated radioactivity
evidenced by a decrease in uptake after pretreatment with unlabelled
progesterone.
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DISCUSSION
H 502C 13 the first progestin reportea to be
.ore effective
than progesterone as both a facilitator and Inhibitor of sexual
behavior. Horprogesterone which is also a 19-norprogestin is 20
tl»es
.ore effective than progesterone In facilitating sexual behavior
m fe^le guinea pigs (Kind. 1964). Medroxyprogesterone (><-„ethyl-
W-acetoxypre6n-4-ene-3.20-dlone) is several ti.es
.ore effective
than progesterone in facilitating sexual behavior In female rats
(Meyerson, I967). Neither of these steroids has been tested for
inhibitory effects.
The biochemical experiments represent the first report of nuclear
binding Of a p-ogestln In rat tealn. although binding has been re-
ported in guinea pigs' brains using autoradlc^aphy (Sar 4 Stumpf,
1973). Taken as a whole, the behavioral experiments and the biochem-
ical experiments are quite consistent with each other and with the
hypothesis that brain cell nuclear binding is Involved in behavioral
responses to progestins.
There is, of course, an alternative explanation for the effective-
ness of R 5020 on sexual behavior. Slowed rate of metabolism of the
synthetic progestin, medroxyprogesterone acetate, has already been
suggested as the basis of its hypereffectiveness in uterine res-
ponses (Feil, Miljkovic A Bardin, 1976). Although this explanation
cannot be overlooked, we also cannot overlook the fact that R 5020 is
50 times more effective than progesterone at a very short time after
Injection (i.e. facilitation of sexual behavior 5-? hours after
injection). It is. however, not unlikely that a combination of factors
Is Involved in R 5020 's increased potency.
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The high concentration of ^H-R 502O binding by pituitary cell
nuclei, though probably not relevant to behavior, is pertinent to an
understanding of progesterone 's influences on reproductive physiology.
That is. the pituitary is believed to be one site of action for
progesterone 's effects on gonadotropin release (Barraclough. I973.
Feder & Maxrone. 1977; Schally, Arimura & Kastin, 1973). Similarly,
the high concentration in the hypothalamus is consistent with the
results of cannula implant studies, which have demonstrated that
the hypothalamus is one site of action for progesterone 's facilition
of rat (Powers, 1972; Ross et al., I97I; Ward et al., 1975) and
guinea pig (Morin & Feder, 1974b) sexual behavior. The hypothalamus
also seems to be a site of action for progesterone 's inhibition of
rat sexual behr-.vior (Marrone & Feder, personal communication).
The lack of binding in the midbrain is quite puzzling since
cannula implant studies have consistently found the midbrain to be
one site of action for progesterone 's effects on sexual behavior.
Unfortunately, the direction of the results are conflicting. In
guinea pigs (Morin & Feder, 1974c), hamsters (DeBold et al., I976) and
rats (Yanase & Gorski, 1976), the midbrain is reported to be a
site of inhibition of sexual behavior. Conversely, Ross et al.,
(1971) and Luttge and Gughes (1976) have reported facilitation of rat
sexual behavior with progesterone implants in the midbrain reticular
formation and interpeduncular nucleus, respectively. Unfortunately,
until the gross interlaboratory and potential interspecies differences
in the anatomical localization of progesterone 's effects are recon-
ciled, it cannot be inferred from implant data that nuclear binding
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is involved, in only facilitation or only inhibition. Neverthe-
less, implants of progesterone in the midbrain affect sexual behavior.
saturable, nuclear binding of R 5020 could not be observed in this
area. Either the procedures used do not afford sufficient resolution
to observe what may be very low concentration of binding or alter-
natively, progestins may have a different subcellular site of action
in this area, perhaps at the neuronal synapse (Janowsky & Davis. I976).
Finally, the dependence of the progestin binding on estrogen
priming is quite exciting. It is of course consistent with the
dependence on estrogen priming for the synthesis of progestin
receptors (Faber, Sandmann & Stavely, 1972a, 1972b; Freifeld, Fell &
Bardin. 197^; Leavitt et al.
. 1974j Milgrom. Atger & Baulieu, I97O;
Luu Thi. Baulieu & Milgrom. 1975) and uptake of ^H-progesterone in
peripheral tissues (Chen & Leavitt, I975. Falk & Bardin, I97O;
Leavitt & Blaha. 1972), as well as for progesterone' s facilitation
of behavior (Feder & Marrone, 1977? Marin, 1977). These results
also suggest that estrogen and progesterone may act on the same cells
in progestin-responsive neural tissues.
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GENERAL DISCUSSION
Section I demonstrated that with appropriate doses, progesterone
can inhibit sexual receptivity in rats in both a concurrent and
sequential inhibition procedure. These experiments raise a number of
interesting questions concerning progesterone 's role in the modulation
of sexual receptivity.
Inhibition of sexual behavior in rats requires approximately 1
- 2.5 mg of progesterone compared to less than 1 mg required for
guinea pigs in similar, but not identical procedures (Wallen et al.
,
1975; Zucker, I966). What is the basis for the elevated levels
required in rats? Experiment 5 addressed this question by demonstrat-
ing that 1 mg of progesterone, which did not inhibit concurrently
when injected simultaneously with EB, was effective when divided
into five repeated injections over a period of 16 hours. The
results are consistent with the notion that maintained neural levels
of progesterone may be necessary for inhibition. They are also
consistent with an interpretation that blood plasma levels must be
maintained at a sufficiently elevated level, or that a sustained
supply of unmetabolized progesterone must be maintained. The
species difference could be due to shorter retention of progesterone
in the brain or plasma or the rapid metabolism in rats.
The fact that the same types of dose relationships held for
concurrent inhibition as sequential inhibition suggest that these
two clsLSses of inhibition may be essentially the same phenomenon.
Nevertheless, we are left to explain the fact that concurrent inhi-
bition requires 2.5 mg of progesterone^ but sequential inhibition
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requires only 1 mg of progesterone. Experiment 9 demonstrated that
the shorter interval between progesterone injection and testing i;.
the sequential inhibition procedure is probably not responsible. It
remains to be explained why less progesterone is required to
inhibit sequentially than is required to inhibit concurrently. At
the time of the progesterone injection in concurrent inhibition,
plasma estrogen levels are their highest, but conditioning has just
begun. The solution to the problem will likely require a prior
understanding of what estrogen conditioning is at a neurochemical
level.
Progesterone requires estrogen priming in order to facilitate
sexual behavior. The higher the estrogen dose, the lower the dose
of progesterone needed to facilitate (Whalen, 1974). Why then,
does increasing the priming dose of estradiol decrease responsivity
to progesterone 's inhibitory influences? This suggests that the
dose required for facilitation is dose-dependent on estradiol but the
dose required for inhibition is inversely related to the dose of
estradiol. Does this imply that progesterone 's facilitatory and
inhibitory effects are mediated by distinct neurochemical mechanisms
with differing dependence on estradiol?
A mechanism of action for progesterone must be able to resolve
all of these questions, as well as account for the results of a
recent experiment by Marrone, Rodriguez-Sierra and Feder (197?)
which suggested that progesterone 's inhibitory effects can occur
with as short a latency as the facilitatory effects. When the heat
duration of rats was extended by injecting a large dose of progester-
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one, heat could be terminated vdthin four ho^rrs ty a second dose of
progesterone. Facilitation can occir in less than an hour of ad-
ministration when injected intravenously (Lisk, I96O; Meyerson, 1972).
It has yet to be seen whether inhibition can occur quite this rapidly.
Section II offers evidence that progesterone does not inhibit
sexual behavior by the same mechanism as the synthetic estrogen
Eintagonists
.
With two conflicting reports (Anderson & Greenwald,
1969; Ciaccio & Lisk, 1972) progesterone does not diminish whole
homogenate or cell nuclear binding of estradiol in the brain of any
rodent species that has been studied. Progesterone does not affect
estradiol's interaction with the estrogen receptor, nor affect the
replenishment of the estrogen receptor in the hypothalamus.
Conversely, synthetic estrogen antagonists are effective in inhibiting
each of these steps. The behavioral effects of progesterone and the
synthetic estrogen ajitagonist, CI-628, are dissociable behaviorally
as well; CI-628 shortens heat duration, and increasing progesterone
doses actually lengthen it.
Recently, the suggestion has been made that lengthy progesterone
3
pretreatment may actually increase in vivo -^H-estradiol uptake in
preoptic area, hypothalamus and pituitary and in vitro nuclear
"binding of -^H-estradiol in the hypothalamus and pituitary (Reuter &
Lisk, 1976). These results are difficult to interpret since, on
the basis of current: hypotheses of estrogen's mechanism of action,
one would predict from these results that progesterone pretreatment
would increase responsiveness to estrogen, which it does not.
Although Section II only demonstrated a mechanism by which
progesterone probably does not affect sexual behavior. Section III
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has proposed a testable hypothesis of how it migh affect sexual
behavior. As already discussed, the cell nuclear binding of a
progestin. 3h.r 302O is estrogen dependent, lending credence to the
hypothesis that the "two-step" mechanism of steroid action may be
involved in progesterone 's effects on sexual behavior. The speci-
ficity with which R 5020 binds to progestin receptors allows the
results of ^h-R 502O binding studies to be generalized to progesterone
itself (Raynaud. 197?)
.
The rapidity with which progesterone 's facilitatory andinhibi-
tory actions occur is perhaps the most troublesome argument against
a cell nuclear site of action. Although we are accustomed to thinking
that an effect of a steroid hormone on sexual behavior involving
genetic expression would require many hours to exert itself (McEwen,
1976; McEwen et al.. 1975), this need not be the case. Early events
of estrogen's action in the uterus occur within a few hours (Anderson,
Peck & Clark. 1975). Certainly the "induced protein" is detectable
within an hour of estrogen administration (Barnea & Gorski. I970).
We need, only postulate that early products of progesterone 's
effects on genetic expression are involved in progesterone 's facili-
tation and/or inhibition of sexual behavior. It should be emphasized
that a proposed nuclear site of action for progesterone in no way
precludes effects on the cell membrane (Marrone & Feder. 1977), either
independent of, or secondary to the nuclear mechanism.
This dissertation could hardly be considered complete without
at least scaae speculations as to the biological significance, if any,
of progesterone 's effects on sexual behavior in rats. Joslyn, Feder
and Goy (1971) have suggested that the function of the synergistic
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action of progesterone in female rodents may be for estrous behavior
and ovulation to become "temporally bound to each other in the normal
cycle...." An inseparable link between sexual receptivity and
ovulation is an association with obvious adaptive significance.
Progesterone sequentially inhibits sexual behavior in ovari-
ectomized rats, as endogenous progesterone may during the estrous
cycle. During the estrous cycle, it would seem likely that the
progesterone-induced sequential inhibition may more firmly link
sexual receptivity with ovulation by opening and then closing a
discrete window of time during which both may occur.
Progesterone concurrently inhibits in ovariectomized rats, and
may contribute to the absence of sexual behavior during pregnancy
(Hardy, 1970). Following copulation, there ensues an immediate
postcopulatory period of inhibition (Hardy & DeBold, 1972) and an
elevation of progesterone levels in blood plasma within six hours
(Adler, Resko & Goy, 1970). Perhaps concurrent inhibition by
progesterone is a mechanism that operates as a continuation of
the neural inhibition of sexual receptivity that has been described.
(Lodder & Zeilmaker, 1976).
Lastly, it must be pointed out that progesterone 's effects on
sexual behavior should not be dismissed as sin interesting artifact
of laboratory rodents. Progesterone antagonizes estrogen's induction
of sexual behavior .in guinea pigs, hamsters, rats (Feder & Marrone,
1977; Morin, 1977; Young, I969), mice (Edwards, 1970), rabbits (Beyer,
Vidal & McDonald, I969), sheep and goats (Phillips, Fraps and Frank,
19^5), swine (Day, Anderson, Hazel Sc Melampy, 1959) and cows (Carrick
& Shelton, I969). Thus, even if it may not be a universal principle,
progesterone *s inhibition of sexual behavior is certainly widespread.
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